[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 6853
1. Lademann J, Meinke M, Sterry W, Patzelt A: [How safe are nanoparticles?]. Hautarzt; 2009 Apr;60(4):305-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • As a component of sunscreens, the nanoparticles are supposed to remain on the skin surface or in the upper most layers of the stratum corneum to protect the skin against UV-radiation of the sun.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Adv Drug Deliv Rev. 2002 Nov 1;54 Suppl 1:S31-40 [12460714.001]
  • [Cites] Crit Rev Toxicol. 2007 Mar;37(3):251-77 [17453934.001]
  • [Cites] Skin Pharmacol Physiol. 2007;20(1):57-64 [17035723.001]
  • [Cites] Arzneimittelforschung. 1992 Jul;42(7):983-5 [1418067.001]
  • [Cites] Eur J Cell Biol. 2002 Aug;81(8):419-35 [12234014.001]
  • [Cites] Skin Pharmacol Appl Skin Physiol. 2003 Jan-Feb;16(1):28-35 [12566826.001]
  • [Cites] J Invest Dermatol. 2006 Aug;126(8):1728-32 [16645589.001]
  • [Cites] J Invest Dermatol. 2004 Jul;123(1):168-76 [15191557.001]
  • [Cites] Skin Pharmacol Physiol. 2006;19(4):232-6 [16679826.001]
  • [Cites] J Control Release. 2004 Jul 7;97(3):477-84 [15212879.001]
  • [Cites] Skin Pharmacol Appl Skin Physiol. 1999 Jan-Apr;12(1-2):34-45 [10325582.001]
  • [Cites] Skin Pharmacol Physiol. 2008;21(3):136-49 [18523411.001]
  • [Cites] Eur J Pharm Biopharm. 2007 May;66(2):159-64 [17169540.001]
  • [Cites] Skin Pharmacol Physiol. 2005 Jul-Aug;18(4):180-5 [15908758.001]
  • [Cites] Eur J Pharm Biopharm. 2008 Sep;70(1):234-8 [18455379.001]
  • [Cites] J Invest Dermatol. 2004 Jan;122(1):14-9 [14962084.001]
  • [Cites] J Invest Dermatol. 2006 Jun;126(6):1316-22 [16614727.001]
  • [Cites] J Liposome Res. 2002 Feb-May;12(1-2):143-8 [12604048.001]
  • [Cites] Clin Dermatol. 2008 Jul-Aug;26(4):341-6 [18691513.001]
  • [Cites] Skin Pharmacol Appl Skin Physiol. 1999 Sep-Oct;12(5):247-56 [10461093.001]
  • [Cites] Skin Pharmacol Physiol. 2008;21(3):150-5 [18523412.001]
  • [Cites] J Biomed Opt. 2004 Nov-Dec;9(6):1358-62 [15568958.001]
  • [Cites] J Invest Dermatol. 2005 Aug;125(2):264-9 [16098036.001]
  • [Cites] J Ultrastruct Res. 1979 Apr;67(1):73-8 [448791.001]
  • (PMID = 19221705.001).
  • [ISSN] 1432-1173
  • [Journal-full-title] Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
  • [ISO-abbreviation] Hautarzt
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Dermatologic Agents; 0 / Drug Carriers
  • [Number-of-references] 29
  •  go-up   go-down


2. Rüfer F, Sander S, Klettner A, Frimpong-Boateng A, Erb C: Characterization of the thinnest point of the cornea compared with the central corneal thickness in normal subjects. Cornea; 2009 Feb;28(2):177-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization of the thinnest point of the cornea compared with the central corneal thickness in normal subjects.
  • INTRODUCTION: For ongoing progress in refractive surgery, exact knowledge about the anatomical properties of the cornea is useful.
  • Thus, the aim of the study was to characterize the thinnest point of the cornea compared with the central corneal thickness in normal subjects and to investigate with regard to influencing factors such as sex, age, refraction, and intraocular pressure.
  • MATERIALS AND METHODS: The central corneal thickness and the thinnest point of the cornea were determined with the Orbscan II in 390 white normal subjects.
  • RESULTS: In the right eyes, the mean central corneal thickness was 548 +/- 37 microm and the thinnest point 537 +/- 37 microm.
  • In the left eyes, the mean central corneal thickness was 547 +/- 37 microm and the thinnest point 535 +/- 39 microm.
  • The difference between the central corneal thickness and the thinnest point was found to be significant in both eyes in paired t test (P > 0.001).
  • No influence of sex, refraction, and intraocular pressure on the thickness of the thinnest point of the cornea could be observed.
  • The difference between central corneal thickness and thickness at the thinnest point was not subject to a statistically significant influence of age.
  • CONCLUSIONS: In the calculation of the residual corneal layer thickness in laser refractive surgery, the thinnest point of the cornea should form the basis.
  • [MeSH-major] Cornea / anatomy & histology. Corneal Topography / methods

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19158561.001).
  • [ISSN] 1536-4798
  • [Journal-full-title] Cornea
  • [ISO-abbreviation] Cornea
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


3. Coste R, Cornand E, Denis D: [Central corneal thickness in a pediatric population using a noncontact specular microscope: a study of 405 cases]. J Fr Ophtalmol; 2008 Mar;31(3):273-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Central corneal thickness in a pediatric population using a noncontact specular microscope: a study of 405 cases].
  • [Transliterated title] Pachymétrie cornéenne centrale dans la population pédiatrique par microscopie spéculaire non-contact: à propos de 405 cas.
  • AIM: Central corneal thickness has become very important in the interpretation of intraocular pressure.
  • Exclusion criteria were a history of ocular surgery, lens wearers, and any disease that could alter the cornea.
  • [MeSH-major] Cornea / anatomy & histology. Cornea / cytology. Surgical Instruments

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18404120.001).
  • [ISSN] 1773-0597
  • [Journal-full-title] Journal français d'ophtalmologie
  • [ISO-abbreviation] J Fr Ophtalmol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


Advertisement
4. Thomas PB, Liu YH, Zhuang FF, Selvam S, Song SW, Smith RE, Trousdale MD, Yiu SC: Identification of Notch-1 expression in the limbal basal epithelium. Mol Vis; 2007 Mar 01;13:337-44
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The central cornea was almost devoid of Notch-1.
  • Further studies and characterization of the Notch pathway in corneal development will provide valuable clues for the identification of stem cells.
  • [MeSH-major] Epithelium, Corneal / metabolism. Limbus Corneae / metabolism. Receptors, Notch / metabolism
  • [MeSH-minor] ATP Binding Cassette Transporter, Sub-Family G, Member 2. ATP-Binding Cassette Transporters / metabolism. Animals. Antibody Specificity / immunology. COS Cells. Cells, Cultured. Cercopithecus aethiops. Gene Expression Profiling. Humans. Integrin alpha6 / genetics. Integrin alpha6 / metabolism. Integrin beta1 / genetics. Integrin beta1 / metabolism. Neoplasm Proteins / metabolism. Protein Transport

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Genes Dev. 1989 Aug;3(8):1113-29 [2792756.001]
  • [Cites] Cell. 1989 Apr 21;57(2):201-9 [2702690.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1991 May;32(6):1864-75 [2032808.001]
  • [Cites] Cornea. 1994 Sep;13(5):389-400 [7995060.001]
  • [Cites] Cell. 1995 Jan 13;80(1):83-93 [7813021.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6414-8 [7604005.001]
  • [Cites] J Invest Dermatol. 1995 Jul;105(1):14-21 [7542296.001]
  • [Cites] Mech Dev. 1995 Sep;53(1):73-85 [8555113.001]
  • [Cites] J Hematother. 1996 Jun;5(3):237-45 [8817390.001]
  • [Cites] Cornea. 1996 Nov;15(6):549-56 [8899265.001]
  • [Cites] Development. 1996 Dec;122(12):3765-73 [9012498.001]
  • [Cites] Lancet. 1997 Apr 5;349(9057):990-3 [9100626.001]
  • [Cites] J Cell Sci. 1998 Oct;111 ( Pt 19):2867-75 [9730979.001]
  • [Cites] J Cell Sci. 1998 Nov;111 ( Pt 21):3179-88 [9763512.001]
  • [Cites] Development. 1999 Apr;126(8):1689-702 [10079231.001]
  • [Cites] EMBO J. 1999 Apr 15;18(8):2196-207 [10205173.001]
  • [Cites] Science. 1999 Apr 30;284(5415):770-6 [10221902.001]
  • [Cites] Development. 1999 Jun;126(11):2409-18 [10226000.001]
  • [Cites] Nat Immunol. 2005 Mar;6(3):314-22 [15665828.001]
  • [Cites] J Cell Sci. 2005 Apr 15;118(Pt 8):1715-24 [15811951.001]
  • [Cites] Nature. 2005 Jun 16;435(7044):964-8 [15959516.001]
  • [Cites] Cancer Res. 2005 Aug 1;65(15):6640-50 [16061644.001]
  • [Cites] Indian J Ophthalmol. 1999 Mar;47(1):3-9 [16130277.001]
  • [Cites] Dev Biol. 2006 Feb 1;290(1):66-80 [16360140.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Jun 16;344(4):1278-83 [16650829.001]
  • [Cites] Stem Cells. 2006 May;24(5):1265-73 [16424398.001]
  • [Cites] Cancer Res. 2006 Sep 1;66(17):8598-607 [16951173.001]
  • [Cites] J Invest Dermatol. 2000 Mar;114(3):413-20 [10692098.001]
  • [Cites] Surv Ophthalmol. 2000 Mar-Apr;44(5):415-25 [10734241.001]
  • [Cites] N Engl J Med. 2000 Jul 13;343(2):86-93 [10891515.001]
  • [Cites] Cornea. 2000 Jul;19(4):421-6 [10928750.001]
  • [Cites] Nat Med. 2000 Nov;6(11):1278-81 [11062542.001]
  • [Cites] J Exp Med. 2000 Nov 6;192(9):1365-72 [11067884.001]
  • [Cites] Dev Biol. 2000 Dec 15;228(2):151-65 [11112321.001]
  • [Cites] Nat Med. 2001 Sep;7(9):1028-34 [11533706.001]
  • [Cites] Genes Dev. 2002 Apr 1;16(7):846-58 [11937492.001]
  • [Cites] Annu Rev Neurosci. 2002;25:471-90 [12052917.001]
  • [Cites] Nat Genet. 2003 Mar;33(3):416-21 [12590261.001]
  • [Cites] Semin Cell Dev Biol. 2003 Apr;14(2):143-50 [12651098.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Jul;88(7):2972-82 [12843129.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4275-81 [14507871.001]
  • [Cites] Br J Ophthalmol. 2004 Mar;88(3):393-8 [14977776.001]
  • [Cites] Stem Cells. 2004;22(3):355-66 [15153612.001]
  • [Cites] Exp Eye Res. 2004 Jul;79(1):41-9 [15183099.001]
  • [Cites] Development. 2004 Oct;131(20):4955-64 [15371309.001]
  • [Cites] Nature. 1971 Feb 19;229(5286):560-1 [4925352.001]
  • [Cites] J Cell Biol. 1986 Jul;103(1):49-62 [2424919.001]
  • [Cites] J Cell Biol. 1991 May;113(3):657-69 [2016340.001]
  • (PMID = 17392684.001).
  • [ISSN] 1090-0535
  • [Journal-full-title] Molecular vision
  • [ISO-abbreviation] Mol. Vis.
  • [Language] eng
  • [Grant] United States / NEI NIH HHS / EY / P30 EY003040; United States / NEI NIH HHS / EY / R03 EY014392; United States / NEI NIH HHS / EY / EY014392; United States / NEI NIH HHS / EY / EY03040
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ABCG2 protein, human; 0 / ATP Binding Cassette Transporter, Sub-Family G, Member 2; 0 / ATP-Binding Cassette Transporters; 0 / Integrin alpha6; 0 / Integrin beta1; 0 / Neoplasm Proteins; 0 / Receptors, Notch
  • [Other-IDs] NLM/ PMC2633467
  •  go-up   go-down


5. Kim JY, Kim MJ, Kim TI, Choi HJ, Pak JH, Tchah H: A femtosecond laser creates a stronger flap than a mechanical microkeratome. Invest Ophthalmol Vis Sci; 2006 Feb;47(2):599-604
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To compare corneal flaps made with a femtosecond (FS) laser with those made with a mechanical microkeratome (MM) in rabbits, measuring early postoperative inflammation and apoptosis and late postoperative adhesion strength.
  • RESULTS: Study 1: Inflammatory cell infiltration in the central cornea was significantly greater in the FS group than in the MM group at 4 and 24 hours (P < 0.05) and was significantly greater in the FS+LASIK group than in the MM+LASIK group at 24 hours (P < 0.05).
  • CONCLUSIONS: The FS laser produces greater corneal stromal inflammation than the MM early postoperatively without any increase in apoptosis and stronger flap adhesion late postoperatively.
  • [MeSH-major] Corneal Stroma / physiopathology. Corneal Stroma / surgery. Keratomileusis, Laser In Situ / methods. Surgical Flaps. Wound Healing / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16431956.001).
  • [ISSN] 0146-0404
  • [Journal-full-title] Investigative ophthalmology & visual science
  • [ISO-abbreviation] Invest. Ophthalmol. Vis. Sci.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


6. Hicks CR, Macvie O, Crawford GJ, Constable IJ: A risk score as part of an evidence-based approach to the selection of corneal replacement surgery. Cornea; 2005 Jul;24(5):523-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A risk score as part of an evidence-based approach to the selection of corneal replacement surgery.
  • PURPOSE: There is currently no standardized methodology that permits preoperative prediction of the surgical technique or drug regimen for corneal grafting most likely to succeed for an individual patient.
  • METHODS: The Risk Score (RS) is based on factors shown to reduce the probability of 1-year survival of conventional PK in increments, using published Australian Corneal Graft Registry data.
  • To asses its validity, Kaplan-Meier survival curves from 156 corneal replacement surgeries, stratified by preoperative RS, were used to derive the probability of survival at 1 year for donor PK, with or without systemic immunosuppression, and for synthetic PK with the AlphaCor artificial cornea.
  • CONCLUSIONS: This study was designed to test a method that allows objective comparison of outcomes of different methods of corneal replacement for different risk categories.
  • [MeSH-major] Cornea / physiology. Corneal Transplantation / methods. Graft Survival / physiology
  • [MeSH-minor] Artificial Organs. Corneal Diseases / surgery. Evidence-Based Medicine. Female. Follow-Up Studies. Humans. Immunosuppressive Agents / therapeutic use. Male. Probability. Prostheses and Implants. Risk Assessment. Tissue Donors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15968155.001).
  • [ISSN] 0277-3740
  • [Journal-full-title] Cornea
  • [ISO-abbreviation] Cornea
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Immunosuppressive Agents
  •  go-up   go-down


7. Mohan RR, Sharma A, Netto MV, Sinha S, Wilson SE: Gene therapy in the cornea. Prog Retin Eye Res; 2005 Sep;24(5):537-59
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gene therapy in the cornea.
  • The cornea is an excellent candidate for gene therapy because of its accessibility and immune-privileged nature.
  • In the last two decades, various viral vectors, such as adeno, adeno-associated, retro, lenti, and herpes simplex, as well as non-viral methods, were examined for introducing DNA into corneal cells in vitro, in vivo and ex vivo.
  • Most of these studies used fluorescent or non-fluorescent marker genes to track the level and duration of transgene expression in corneal cells.
  • However, limited studies were directed to evaluate prospects of gene-based interventions for corneal diseases or disorders such as allograft rejection, laser-induced post-operative haze, herpes simplex keratitis, and wound healing in animal models.
  • We will review the successes and obstacles impeding gene therapy approaches used for delivering genes into the cornea.
  • [MeSH-major] Corneal Diseases / therapy. Genetic Therapy
  • [MeSH-minor] Animals. Cornea / physiology. Corneal Dystrophies, Hereditary / therapy. Corneal Opacity / therapy. Corneal Transplantation. Genetic Vectors. Graft Survival. Humans. Wound Healing

  • MedlinePlus Health Information. consumer health - Corneal Disorders.
  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15955719.001).
  • [ISSN] 1350-9462
  • [Journal-full-title] Progress in retinal and eye research
  • [ISO-abbreviation] Prog Retin Eye Res
  • [Language] eng
  • [Grant] United States / NEI NIH HHS / EY / EY10056
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
  • [Publication-country] England
  • [Number-of-references] 167
  •  go-up   go-down


8. Piekutowska A, Pin D, Rème CA, Gatto H, Haftek M: Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs. J Comp Pathol; 2008 May;138(4):197-203
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs.
  • Canine atopic dermatitis (AD) is characterized ultrastructurally by disorganization of the lamellar lipids (LLs) in the stratum corneum (SC), similar to that seen in the human disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18374938.001).
  • [ISSN] 0021-9975
  • [Journal-full-title] Journal of comparative pathology
  • [ISO-abbreviation] J. Comp. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Lipids
  •  go-up   go-down


9. Cejka C, Pláteník J, Buchal R, Guryca V, Sirc J, Vejrazka M, Crkovská J, Ardan T, Michálek J, Brůnová B, Cejková J: Effect of two different UVA doses on the rabbit cornea and lens. Photochem Photobiol; 2009 May-Jun;85(3):794-800
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of two different UVA doses on the rabbit cornea and lens.
  • The aim of the present paper was to examine the irradiation effect of two doses of UVA rays (365 nm) on the rabbit cornea and lens.
  • Absorption spectra of the whole corneal centers were recorded over the UV-VIS (visible) spectral range.
  • Levels of antioxidant and prooxidant enzymes, nitric oxide synthases and nitric oxide (indirectly measured as nitrate concentration) were investigated in the cornea.
  • Malondialdehyde, a byproduct of lipid peroxidation, was examined in the cornea and lens.
  • Otherwise, UVA rays at either dose did not significantly change corneal light absorption properties and did not cause statistically significant metabolic changes in the cornea or lens.
  • In conclusion, UVA rays at the employed doses did not evoke harmful effects in the cornea or lens.
  • [MeSH-major] Cornea / radiation effects. Lens, Crystalline / radiation effects. Ultraviolet Rays

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19076313.001).
  • [ISSN] 0031-8655
  • [Journal-full-title] Photochemistry and photobiology
  • [ISO-abbreviation] Photochem. Photobiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


10. Sztramska A, Piwiński M, Chwirot BW: Quantitative measurements of formalin-induced fluorescence for differential diagnostics of melanomas and lesions of human skin. Melanoma Res; 2010 Oct;20(5):408-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Microscopic digital imaging was used to quantitatively determine the fluorescence intensity of 53 primary melanomas and 32 benign lesions.
  • Receiver operating characteristics (ROC) analysis of the algorithm yielded area under the curve=0.84 +/- 0.05 for melanocytic cells present in the stratum corneum.
  • Our results clearly indicate that the FIF emitting molecules (most probably 5-S-cysteinyldopa) are present in melanomas at the concentration significantly higher than in benign lesions.
  • [MeSH-major] Formaldehyde / pharmacology. Luminescent Measurements / methods. Melanoma / diagnosis. Skin Diseases / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Algorithms. Diagnosis, Differential. Feasibility Studies. Fluorescence. Humans. Paraffin Embedding. ROC Curve. Sensitivity and Specificity. Tumor Burden

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • Hazardous Substances Data Bank. FORMALDEHYDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20661163.001).
  • [ISSN] 1473-5636
  • [Journal-full-title] Melanoma research
  • [ISO-abbreviation] Melanoma Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Validation Studies
  • [Publication-country] England
  • [Chemical-registry-number] 1HG84L3525 / Formaldehyde
  •  go-up   go-down


11. Rastogi R, Anand S, Dinda AK, Koul V: Investigation on the synergistic effect of a combination of chemical enhancers and modulated iontophoresis for transdermal delivery of insulin. Drug Dev Ind Pharm; 2010 Aug;36(8):993-1004
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In-depth analysis of infra-red spectra revealed that each of the enhancers acted differentially on lipid-protein domains of the stratum corneum thereby supporting the observed synergism.

  • MedlinePlus Health Information. consumer health - Diabetes Medicines.
  • Hazardous Substances Data Bank. OLEIC ACID .
  • Hazardous Substances Data Bank. CINEOLE .
  • Hazardous Substances Data Bank. DEOXYCHOLIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20334541.001).
  • [ISSN] 1520-5762
  • [Journal-full-title] Drug development and industrial pharmacy
  • [ISO-abbreviation] Drug Dev Ind Pharm
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Blood Glucose; 0 / Cyclohexanols; 0 / Hydrogels; 0 / Hypoglycemic Agents; 0 / Insulin; 0 / Monoterpenes; 0 / Pharmaceutical Vehicles; 005990WHZZ / Deoxycholic Acid; 2UMI9U37CP / Oleic Acid; RV6J6604TK / eucalyptol
  •  go-up   go-down


12. Kim SK, Noh YH, Koo JR, Yun HS: Effect of expression of genes in the sphingolipid synthesis pathway on the biosynthesis of ceramide in Saccharomyces cerevisiae. J Microbiol Biotechnol; 2010 Feb;20(2):356-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ceramide is important not only for the maintenance of the barrier function of the skin but also for the water-binding capacity of the stratum corneum.

  • Saccharomyces Genome Database. Saccharomyces Genome Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20208441.001).
  • [ISSN] 1017-7825
  • [Journal-full-title] Journal of microbiology and biotechnology
  • [ISO-abbreviation] J. Microbiol. Biotechnol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Ceramides; 0 / Saccharomyces cerevisiae Proteins; 0 / Sphingolipids
  •  go-up   go-down


13. Henning A, Neumann D, Kostka KH, Lehr CM, Schaefer UF: Influence of human skin specimens consisting of different skin layers on the result of in vitro permeation experiments. Skin Pharmacol Physiol; 2008;21(2):81-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • FFA permeation across human (1) trypsin-isolated stratum corneum, (2) heat-separated epidermis and (3) dermis, (4) dermatomized skin and (5) full-thickness skin (FTS) from either a hydrophilic or lipophilic donor was investigated in Franz-type diffusion cells.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 S. Karger AG, Basel
  • (PMID = 18187967.001).
  • [ISSN] 1660-5535
  • [Journal-full-title] Skin pharmacology and physiology
  • [ISO-abbreviation] Skin Pharmacol Physiol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents; 0 / Pharmaceutical Vehicles; 60GCX7Y6BH / Flufenamic Acid
  •  go-up   go-down


14. Gunt HB, Miller MA, Kasting GB: Water diffusivity in human nail plate. J Pharm Sci; 2007 Dec;96(12):3352-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The diffusivity values, which may be understood in terms of the equilibrium water content of the nail and a free volume theory for diffusion in hydrophilic polymers, were consistent with water diffusivities measured in other keratinized tissues including wool, horn and the corneocyte phase of stratum corneum.

  • Hazardous Substances Data Bank. TRITIUM, RADIOACTIVE .
  • Hazardous Substances Data Bank. Water .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • (PMID = 17786922.001).
  • [ISSN] 0022-3549
  • [Journal-full-title] Journal of pharmaceutical sciences
  • [ISO-abbreviation] J Pharm Sci
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 059QF0KO0R / Water; 10028-17-8 / Tritium; 68238-35-7 / Keratins
  •  go-up   go-down


15. Astner S, Burnett N, Rius-Díaz F, Doukas AG, González S, Gonzalez E: Irritant contact dermatitis induced by a common household irritant: a noninvasive evaluation of ethnic variability in skin response. J Am Acad Dermatol; 2006 Mar;54(3):458-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Reflectance confocal microscopy showed stratum corneum disruption, parakeratosis, and spongiosis; these features were more severe in Caucasian participants (P < or = .002).

  • MedlinePlus Health Information. consumer health - African American Health.
  • MedlinePlus Health Information. consumer health - Household Products.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16488297.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


16. Gradisar H, Friedrich J, Krizaj I, Jerala R: Similarities and specificities of fungal keratinolytic proteases: comparison of keratinases of Paecilomyces marquandii and Doratomyces microsporus to some known proteases. Appl Environ Microbiol; 2005 Jul;71(7):3420-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Studies of substrate specificity revealed that skin constituents, such as the stratum corneum, and appendages such as nail but not hair, feather, and wool were efficiently hydrolyzed by the P. marquandii keratinase and about 40% less by the D. microsporus keratinase.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Can J Microbiol. 2000 Nov;46(11):1004-11 [11109488.001]
  • [Cites] Appl Environ Microbiol. 1999 Jun;65(6):2570-6 [10347045.001]
  • [Cites] Extremophiles. 2001 Dec;5(6):399-408 [11778841.001]
  • [Cites] Appl Biochem Biotechnol. 2002 Feb;97(2):123-33 [11996223.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Jun 28;294(5):1138-43 [12074595.001]
  • [Cites] Bioresour Technol. 2003 Feb;86(3):239-43 [12688466.001]
  • [Cites] Nature. 1970 Aug 15;227(5259):680-5 [5432063.001]
  • [Cites] EMBO J. 1984 Jan;3(1):175-8 [6200321.001]
  • [Cites] J Invest Dermatol. 1984 Jul;83(1):32-6 [6203988.001]
  • [Cites] Sabouraudia. 1984;22(3):219-24 [6431619.001]
  • [Cites] J Med Vet Mycol. 1988 Jun;26(3):187-94 [2459364.001]
  • [Cites] Appl Microbiol Biotechnol. 2000 Feb;53(2):196-200 [10709982.001]
  • [Cites] Infect Immun. 1989 Nov;57(11):3479-83 [2478474.001]
  • [Cites] Infect Immun. 1990 Sep;58(9):2856-61 [1696933.001]
  • [Cites] Indian J Exp Biol. 1990 Jun;28(6):575-7 [1698173.001]
  • [Cites] Zentralbl Bakteriol. 1992 Jul;277(2):236-44 [1381647.001]
  • [Cites] Mycopathologia. 1992 Sep;119(3):161-5 [1435957.001]
  • [Cites] Mycoses. 1992 Nov-Dec;35(11-12):343-8 [1284610.001]
  • [Cites] J Biol Chem. 1993 Sep 25;268(27):20143-7 [8376373.001]
  • [Cites] Appl Environ Microbiol. 1995 Apr;61(4):1469-74 [7747965.001]
  • [Cites] Appl Environ Microbiol. 1995 Oct;61(10):3705-10 [7487006.001]
  • [Cites] Biosci Biotechnol Biochem. 1995 Dec;59(12):2239-43 [8611746.001]
  • [Cites] Annu Rev Cell Dev Biol. 1995;11:123-53 [8689554.001]
  • [Cites] Curr Microbiol. 1996 Dec;33(6):364-70 [8900102.001]
  • [Cites] Lett Appl Microbiol. 1998 Jan;26(1):77-80 [9489039.001]
  • [Cites] Med Mycol. 1998 Dec;36(6):395-404 [10206750.001]
  • [Cites] J Protein Chem. 2001 Feb;20(2):165-9 [11563697.001]
  • (PMID = 16000744.001).
  • [ISSN] 0099-2240
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Caseins; 68238-35-7 / Keratins; EC 3.4.- / Peptide Hydrolases; EC 3.4.- / keratinase
  • [Other-IDs] NLM/ PMC1168971
  •  go-up   go-down


17. Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED, Hamilton MG: Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig. Basic Clin Pharmacol Toxicol; 2005 Jul;97(1):35-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It was tentatively concluded that spreading was predominantly a surface phenomena (possibly mediated by capillary movement of the agent through the microrelief or between hair follicles) with little or no contribution from lateral diffusion within the stratum corneum.

  • MedlinePlus Health Information. consumer health - Biodefense and Bioterrorism.
  • MedlinePlus Health Information. consumer health - Chemical Emergencies.
  • Hazardous Substances Data Bank. VX .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15943757.001).
  • [ISSN] 1742-7835
  • [Journal-full-title] Basic & clinical pharmacology & toxicology
  • [ISO-abbreviation] Basic Clin. Pharmacol. Toxicol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Chemical Warfare Agents; 0 / Cholinesterase Inhibitors; 0 / Ointments; 0 / Organothiophosphorus Compounds; 50782-69-9 / VX
  •  go-up   go-down


18. Sieg A, Guy RH, Delgado-Charro MB: Noninvasive and minimally invasive methods for transdermal glucose monitoring. Diabetes Technol Ther; 2005 Feb;7(1):174-97
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The techniques involving transdermal fluid extraction circumvent and/or compromise the barrier function of skin's outermost and least permeable layer, the stratum corneum, by the application of physical energy.

  • MedlinePlus Health Information. consumer health - Blood Sugar.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15738715.001).
  • [ISSN] 1520-9156
  • [Journal-full-title] Diabetes technology & therapeutics
  • [ISO-abbreviation] Diabetes Technol. Ther.
  • [Language] eng
  • [Grant] United States / NIBIB NIH HHS / EB / EB 001420
  • [Publication-type] Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Blood Glucose
  • [Number-of-references] 152
  •  go-up   go-down


19. de Brito Gitirana L, Azevedo RA, Pelli AA: Expression pattern of glycoconjugates in the integument of Bufo ictericus (Anuran, Bufonidae): biochemical and histochemical (lectin) profiles. Tissue Cell; 2007 Dec;39(6):415-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The secretory cells of the mucous gland in the dermis, as well as the interstice between the stratum corneum and the subjacent stratum spinosum in the epidermis exhibit alpha-l-fucose and alpha-galactose residues.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17900644.001).
  • [ISSN] 0040-8166
  • [Journal-full-title] Tissue & cell
  • [ISO-abbreviation] Tissue Cell
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  • [Chemical-registry-number] 0 / Glycoconjugates; 0 / Lectins
  •  go-up   go-down


20. Holm EA, Wulf HC, Thomassen L, Jemec GB: Assessment of atopic eczema: clinical scoring and noninvasive measurements. Br J Dermatol; 2007 Oct;157(4):674-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Transepidermal water loss, stratum corneum hydration, erythema, scaling and subepidermal oedema were measured.
  • [MeSH-major] Dermatitis, Atopic / diagnosis. Severity of Illness Index


21. Garralda A, Epelde A, Iturralde O, Compains E, Maison C, Altarriba M, Goldaracena MB, Maraví-Poma E: [Cornea transplant]. An Sist Sanit Navar; 2006;29 Suppl 2:163-73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cornea transplant].
  • [Transliterated title] Trasplante de córnea.
  • The keratoplasty, or cornea transplant, is one of the oldest surgical techniques in opthalmology, whose indication are:.
  • 1) tectonic, in order to preserve corneal anatomy and integrity;.
  • 2) clinical, in order to eliminate the inflamed corneal tissue in cases refractory to medical treatment;.
  • [MeSH-major] Corneal Transplantation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16998525.001).
  • [ISSN] 1137-6627
  • [Journal-full-title] Anales del sistema sanitario de Navarra
  • [ISO-abbreviation] An Sist Sanit Navar
  • [Language] spa
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


22. Nakamura T, Kelly JG, Trevisan J, Cooper LJ, Bentley AJ, Carmichael PL, Scott AD, Cotte M, Susini J, Martin-Hirsch PL, Kinoshita S, Fullwood NJ, Martin FL: Microspectroscopy of spectral biomarkers associated with human corneal stem cells. Mol Vis; 2010 Mar 06;16:359-68
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microspectroscopy of spectral biomarkers associated with human corneal stem cells.
  • Because such imaging gives a "biochemical-cell fingerprint" through a cell-sized aperture, we set out to determine whether distinguishing chemical entities associated with putative stem cells (SCs), transit-amplifying (TA) cells, or terminally-differentiated (TD) cells could be identified in human corneal epithelium.
  • METHODS: Desiccated cryosections (10 microm thick) of cornea on barium fluoride infrared transparent windows were interrogated using SRS FTIR microspectroscopy.
  • Spectral image maps to highlight SCs, TA cells, and TD cells of the cornea were then generated.
  • CONCLUSIONS: SRS FTIR microspectroscopy can be employed to identify differential spectral biomarkers of SCs, TA cells, and/or TD cells in human cornea.

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Exp Eye Res. 2004 Mar;78(3):433-46 [15106923.001]
  • [Cites] Faraday Discuss. 2004;126:41-59; discussion 77-92 [14992399.001]
  • [Cites] Nature. 1971 Feb 19;229(5286):560-1 [4925352.001]
  • [Cites] J Cell Biol. 1986 Jul;103(1):49-62 [2424919.001]
  • [Cites] Cell. 1989 Apr 21;57(2):201-9 [2702690.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1991 Jul;32(8):2219-33 [1712763.001]
  • [Cites] Development. 1989 Aug;106(4):619-33 [2562658.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14047-52 [8943058.001]
  • [Cites] Lancet. 1997 Apr 5;349(9057):990-3 [9100626.001]
  • [Cites] Biol Cell. 2005 Apr;97(4):265-76 [15762848.001]
  • [Cites] Biophys J. 2005 May;88(5):3699-706 [15722424.001]
  • [Cites] Biophys J. 2006 May 15;90(10):3783-95 [16500983.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2417-21 [16723451.001]
  • [Cites] Biophys J. 2006 Sep 15;91(6):2282-9 [16798809.001]
  • [Cites] Ophthalmology. 2006 Oct;113(10):1765-72 [16905193.001]
  • [Cites] Biochem Biophys Res Commun. 2007 Jan 5;352(1):213-9 [17141660.001]
  • [Cites] Stem Cells. 2007 Mar;25(3):628-38 [17110619.001]
  • [Cites] Mol Vis. 2007;13:237-42 [17356510.001]
  • [Cites] Biochim Biophys Acta. 2008 Jan;1783(1):98-106 [17916392.001]
  • [Cites] Stem Cells. 2008 Jan;26(1):108-18 [17901405.001]
  • [Cites] Stem Cells. 2008 May;26(5):1265-74 [18292208.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3395-401 [18441310.001]
  • [Cites] Cancer Lett. 2009 Feb 18;274(2):208-17 [18954939.001]
  • [Cites] Anal Chem. 2009 Feb 15;81(4):1324-31 [19152312.001]
  • [Cites] Anal Chem. 2009 Jul 1;81(13):5314-9 [19499925.001]
  • [Cites] Analyst. 2010 Jan;135(1):53-61 [20024181.001]
  • [Cites] Stem Cell Res. 2009 Jul;3(1):15-27 [19393589.001]
  • [Cites] Cornea. 2000 Jan;19(1):65-71 [10632011.001]
  • [Cites] Curr Eye Res. 2000 Mar;20(3):173-7 [10694891.001]
  • [Cites] N Engl J Med. 2000 Jul 13;343(2):86-93 [10891515.001]
  • [Cites] Biopolymers. 2000;57(6):329-35 [11054652.001]
  • [Cites] Exp Eye Res. 2001 Aug;73(2):247-55 [11446775.001]
  • [Cites] J Biomed Opt. 2002 Apr;7(2):248-54 [11966311.001]
  • [Cites] Biophys J. 2003 Sep;85(3):1938-47 [12944306.001]
  • [Cites] Faraday Discuss. 2004;126:27-39; discussion 77-92 [14992398.001]
  • [Cites] J Investig Dermatol Symp Proc. 2004 Sep;9(3):202-7 [15369214.001]
  • (PMID = 20520745.001).
  • [ISSN] 1090-0535
  • [Journal-full-title] Molecular vision
  • [ISO-abbreviation] Mol. Vis.
  • [Language] ENG
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / / BB/D010055/1
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers
  • [Other-IDs] NLM/ PMC2879290
  •  go-up   go-down


23. Dua HS, Miri A, Alomar T, Yeung AM, Said DG: The role of limbal stem cells in corneal epithelial maintenance: testing the dogma. Ophthalmology; 2009 May;116(5):856-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The role of limbal stem cells in corneal epithelial maintenance: testing the dogma.
  • OBJECTIVE: To study and characterize the epithelial cells in patients with a central "island" of normal epithelial cells surrounded with 360 degrees of clinically apparent limbal stem cell (SC) deficiency with conjunctivalization of the limbus and peripheral cornea.
  • PARTICIPANTS: Five human subjects (8 eyes) who presented with total limbal SC deficiency in 1 or both eyes with a central area of normal corneal epithelial cells.
  • METHODS: Clinical slit-lamp examination, aided with fluorescein staining, for evidence of conjunctivalization and in vivo confocal microscopy (IVCM) of the conjunctivalized limbus and peripheral cornea and the normal central corneal epithelium.
  • MAIN OUTCOME MEASURE: Long term survival of normal stratified corneal epithelial cell sheet in the presence of total limbal SC deficiency.
  • RESULTS: In all 8 eyes the diagnosis of limbal SC deficiency was confirmed by clinical and IVCM examination.
  • The central corneal epithelial cells had a normal appearance with polygonal superficial cells, well-defined wing cells, and smaller basal cells.
  • CONCLUSIONS: The existence and survival of a healthy sheet of corneal epithelial cells over the follow-up period, in the presence of clinically apparent total limbal SC deficiency, suggests a limited role of limbal epithelial SC in physiologic homeostasis of the corneal epithelium.
  • [MeSH-major] Conjunctiva / pathology. Corneal Diseases / pathology. Epithelial Cells / cytology. Epithelium, Corneal / cytology. Limbus Corneae / pathology. Stem Cells / physiology

  • MedlinePlus Health Information. consumer health - Corneal Disorders.
  • MedlinePlus Health Information. consumer health - Stem Cells.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19410942.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Birchall W, Wakely L, Wells AP: The influence of scleral flap position and dimensions on intraocular pressure control in experimental trabeculectomy. J Glaucoma; 2006 Aug;15(4):286-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The side incisions were extended sequentially in 0.5-mm steps up to the limbus, then each flap dissected 1 mm further into clear cornea.
  • In each size group, extending flap side incisions to the limbus produced a small nonsignificant fall in mean IOP, whereas flap extension 1 mm into clear cornea led to a significantly lower mean IOP relative to baseline of 43.2% (P<0.05) for large flaps and 35.4% for small flaps (P<0.01).
  • Excessive forward dissection of a scleral flap into the clear cornea, anterior to the sclerostomy may result in increased aqueous outflow and lower IOP.

  • MedlinePlus Health Information. consumer health - Glaucoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16865004.001).
  • [ISSN] 1057-0829
  • [Journal-full-title] Journal of glaucoma
  • [ISO-abbreviation] J. Glaucoma
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


25. Corazza M, Virgili A: Allergic contact dermatitis from ophthalmic products: can pre-treatment with sodium lauryl sulfate increase patch test sensitivity? Contact Dermatitis; 2005 May;52(5):239-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The irritant anionic surfactant sodium lauryl sulfate (SLS) may alter the stratum corneum and increase antigen penetration.

  • Hazardous Substances Data Bank. SODIUM LAURYL SULFATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15898995.001).
  • [ISSN] 0105-1873
  • [Journal-full-title] Contact dermatitis
  • [ISO-abbreviation] Contact Derm.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Allergens; 0 / Ophthalmic Solutions; 368GB5141J / Sodium Dodecyl Sulfate
  •  go-up   go-down


26. Cejková J, Ardan T, Cejka C, Kovaceva J, Zídek Z: Irradiation of the rabbit cornea with UVB rays stimulates the expression of nitric oxide synthases-generated nitric oxide and the formation of cytotoxic nitrogen-related oxidants. Histol Histopathol; 2005 04;20(2):467-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Irradiation of the rabbit cornea with UVB rays stimulates the expression of nitric oxide synthases-generated nitric oxide and the formation of cytotoxic nitrogen-related oxidants.
  • Until now, the role of nitric oxide (NO) in cornea irradiated with UVB rays remains unknown.
  • Results show that in contrast to normal corneas, where of the NOS isomers only endothelial nitric oxide synthase (NOS3) was expressed in a significant amount (in the epithelium and endothelium), in irradiated corneas all NOS isomers (also brain nitric oxide synthase, NOS1, and inducible nitric oxide synthase, NOS2) as well as an indirect measure of ONOO-formation and MDA were gradually expressed, first in the epithelium, the endothelium and the keratocytes beneath the epithelium and finally in the cells of all corneal layers and the inflammatory cells that invaded the corneal stroma.
  • [MeSH-major] Cornea / metabolism. Cornea / radiation effects. Nitric Oxide Synthase / metabolism. Reactive Nitrogen Species / biosynthesis. Tyrosine / analogs & derivatives. Ultraviolet Rays / adverse effects

  • Hazardous Substances Data Bank. NITRIC OXIDE .
  • Hazardous Substances Data Bank. MALONALDEHYDE .
  • Hazardous Substances Data Bank. L-TYROSINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15736051.001).
  • [ISSN] 0213-3911
  • [Journal-full-title] Histology and histopathology
  • [ISO-abbreviation] Histol. Histopathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Nerve Tissue Proteins; 0 / Reactive Nitrogen Species; 14691-52-2 / Peroxynitrous Acid; 31C4KY9ESH / Nitric Oxide; 3604-79-3 / 3-nitrotyrosine; 42HK56048U / Tyrosine; 4Y8F71G49Q / Malondialdehyde; EC 1.14.13.39 / Nitric Oxide Synthase; EC 1.14.13.39 / Nitric Oxide Synthase Type I; EC 1.14.13.39 / Nitric Oxide Synthase Type II; EC 1.14.13.39 / Nitric Oxide Synthase Type III
  •  go-up   go-down


27. Li J, Tang H, Hu X, Chen M, Xie H: Aquaporin-3 gene and protein expression in sun-protected human skin decreases with skin ageing. Australas J Dermatol; 2010 May;51(2):106-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AQP3 null mice have relatively dry skin, reduced skin elasticity, and delayed recovery of barrier function after removal of the stratum corneum which is also present in skin of old people.

  • MedlinePlus Health Information. consumer health - Skin Aging.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20546216.001).
  • [ISSN] 1440-0960
  • [Journal-full-title] The Australasian journal of dermatology
  • [ISO-abbreviation] Australas. J. Dermatol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Aquaporins
  •  go-up   go-down


28. Kamata Y, Taniguchi A, Yamamoto M, Nomura J, Ishihara K, Takahara H, Hibino T, Takeda A: Neutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acids. J Biol Chem; 2009 May 8;284(19):12829-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Filaggrin is a component of the cornified cell envelope and the precursor of free amino acids acting as a natural moisturizing factor in the stratum corneum.

  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biochim Biophys Acta. 1982 Oct 28;719(1):110-7 [7171620.001]
  • [Cites] Protein Pept Lett. 2006;13(2):119-23 [16472072.001]
  • [Cites] Ann N Y Acad Sci. 1985;455:330-42 [2417519.001]
  • [Cites] Dev Biol. 1986 May;115(1):84-92 [3516761.001]
  • [Cites] J Biol Chem. 1989 Jan 25;264(3):1837-45 [2912987.001]
  • [Cites] J Biol Chem. 2006 Aug 11;281(32):22485-92 [16769724.001]
  • [Cites] J Dermatol Sci. 2006 Nov;44(2):63-72 [16973334.001]
  • [Cites] J Biochem. 2007 Jan;141(1):69-76 [17158865.001]
  • [Cites] J Cosmet Dermatol. 2007 Jun;6(2):75-82 [17524122.001]
  • [Cites] Nat Cell Biol. 2007 Jun;9(6):666-74 [17515931.001]
  • [Cites] Trends Mol Med. 2008 Jan;14(1):20-7 [18068483.001]
  • [Cites] J Cell Biol. 2008 Feb 11;180(3):451-8 [18250198.001]
  • [Cites] FASEB J. 2000 Sep;14(12):1837-47 [10973933.001]
  • [Cites] J Invest Dermatol. 2000 Nov;115(5):813-23 [11069618.001]
  • [Cites] J Invest Dermatol. 2000 Dec;115(6):1072-81 [11121144.001]
  • [Cites] Nat Immunol. 2000 Nov;1(5):413-8 [11062501.001]
  • [Cites] Exp Dermatol. 2001 Jun;10(3):193-203 [11380615.001]
  • [Cites] Bioessays. 2003 Nov;25(11):1106-18 [14579251.001]
  • [Cites] J Cell Biol. 2003 Nov 24;163(4):901-10 [14638864.001]
  • [Cites] Dermatol Ther. 2004;17 Suppl 1:43-8 [14728698.001]
  • [Cites] Nature. 1970 Aug 15;227(5259):680-5 [5432063.001]
  • [Cites] Environ Health Perspect. 1989 Mar;80:109-16 [2466639.001]
  • [Cites] Curr Opin Cell Biol. 1989 Dec;1(6):1107-15 [2699799.001]
  • [Cites] J Biol Chem. 1990 Sep 5;265(25):14791-5 [2394696.001]
  • [Cites] J Biol Chem. 1991 Apr 5;266(10):6626-36 [2007607.001]
  • [Cites] Endocr Rev. 1993 Feb;14(1):3-19 [8491153.001]
  • [Cites] J Invest Dermatol. 1993 May;100(5):613-7 [8098344.001]
  • [Cites] J Biol Chem. 1993 Jun 5;268(16):12164-76 [7685034.001]
  • [Cites] J Biol Chem. 1993 Nov 25;268(33):25139-45 [8227077.001]
  • [Cites] J Invest Dermatol. 1994 Nov;103(5):731-41 [7963664.001]
  • [Cites] J Mol Biol. 1995 Feb 17;246(2):273-83 [7869379.001]
  • [Cites] Arch Biochem Biophys. 1995 Feb 20;317(1):62-8 [7872804.001]
  • [Cites] J Biol Chem. 1995 Jul 28;270(30):17702-11 [7543090.001]
  • [Cites] J Biol Chem. 1995 Nov 24;270(47):28193-8 [7499312.001]
  • [Cites] Arch Biochem Biophys. 1996 May 1;329(1):123-6 [8619628.001]
  • [Cites] Biochem Biophys Res Commun. 1996 Aug 23;225(3):712-9 [8780679.001]
  • [Cites] J Biochem. 1996 Aug;120(2):353-9 [8889821.001]
  • [Cites] J Biochem. 1996 Jan;119(1):29-36 [8907172.001]
  • [Cites] J Biol Chem. 1996 Nov 29;271(48):30709-16 [8940048.001]
  • [Cites] J Invest Dermatol. 1997 Feb;108(2):170-8 [9008230.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Jun 27;235(3):652-6 [9207214.001]
  • [Cites] Curr Genet. 1997 Jul;32(1):41-51 [9309169.001]
  • [Cites] J Invest Dermatol. 1998 Apr;110(4):399-404 [9540982.001]
  • [Cites] Cell. 1998 Nov 25;95(5):637-48 [9845366.001]
  • [Cites] Mol Pharmacol. 1998 Dec;54(6):954-61 [9855622.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4680-5 [10200322.001]
  • [Cites] Arch Dermatol Res. 1999 Apr;291(4):238-40 [10335922.001]
  • [Cites] Biochemistry. 1999 Jun 1;38(22):7111-7 [10353821.001]
  • [Cites] J Cell Biol. 2005 Aug 1;170(3):487-96 [16061697.001]
  • [Cites] Cell Mol Life Sci. 2005 Sep;62(17):1984-95 [16091842.001]
  • [Cites] Anal Biochem. 2005 Dec 15;347(2):208-12 [16289080.001]
  • [Cites] J Mol Biol. 1983 Nov 5;170(3):651-73 [6195345.001]
  • (PMID = 19286660.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Amino Acids; 0 / Imines; 0 / Intermediate Filament Proteins; 0 / Peptide Fragments; 0 / Recombinant Proteins; 0 / filaggrin; 29VT07BGDA / Citrulline; EC 3.- / Hydrolases; EC 3.4.11.- / Aminopeptidases; EC 3.4.22.- / Calpain; EC 3.4.22.- / Caspase 14; EC 3.4.22.- / Cysteine Endopeptidases; EC 3.4.22.40 / bleomycin hydrolase; EC 3.5.3.- / peptidylarginine deiminase type III
  • [Other-IDs] NLM/ PMC2676013
  •  go-up   go-down


29. Wiedersberg S, Naik A, Leopold CS, Guy RH: Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability. Br J Dermatol; 2009 Mar;160(3):676-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recent research has examined the dermatopharmacokinetic (DPK) technique, which is based on stratum corneum (SC) tape-stripping.

  • MedlinePlus Health Information. consumer health - Steroids.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18782322.001).
  • [ISSN] 1365-2133
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Validation Studies
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Glucocorticoids; 0 / Pharmaceutical Vehicles; 9IFA5XM7R2 / Betamethasone Valerate
  •  go-up   go-down


30. Zheleznov EA, Fedorov AA, Sheludchenko VM: [Impact of a continuous electric field on corneal healing in an experiment]. Vestn Oftalmol; 2010 Jul-Aug;126(4):30-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Impact of a continuous electric field on corneal healing in an experiment].
  • The impact of a continuous electric field on reepithelization of the standardized erosive wound surface of the cornea was studied in 54 rabbits.
  • Twenty corneal samples were histologically studied 1, 2, 3 days and 3-4 weeks after injury.
  • It has been shown that the use of a continuous electric field does not prevent and, in most cases, it accelerates corneal erosion epithelization.
  • [MeSH-major] Cornea / radiation effects. Corneal Diseases / radiotherapy. Electromagnetic Fields. Wound Healing / radiation effects

  • MedlinePlus Health Information. consumer health - Corneal Disorders.
  • MedlinePlus Health Information. consumer health - Electromagnetic Fields.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20873155.001).
  • [ISSN] 0042-465X
  • [Journal-full-title] Vestnik oftalmologii
  • [ISO-abbreviation] Vestn Oftalmol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


31. Ji RC: Lymphatic endothelial cells, inflammatory lymphangiogenesis, and prospective players. Curr Med Chem; 2007;14(22):2359-68
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • De novo lymphangiogenesis influences different pathological courses via modulating tissue fluid homeostasis, macromolecule absorption, and leukocyte transmigration.
  • The role of lymphangiogenesis in the setting of the inflammatory processes observed in transplants, inflamed cornea, wound healing, acquired lymphedema and tumor invasion, however, remains to be elucidated.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17896984.001).
  • [ISSN] 0929-8673
  • [Journal-full-title] Current medicinal chemistry
  • [ISO-abbreviation] Curr. Med. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Chemokines
  • [Number-of-references] 134
  •  go-up   go-down


32. Young AR: Acute effects of UVR on human eyes and skin. Prog Biophys Mol Biol; 2006 Sep;92(1):80-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The only effect on the eye is inflammation of the cornea (photokeratitis), which is caused by UVB (and non-solar UVC) and resolves without long-term consequences within 48 h.

  • MedlinePlus Health Information. consumer health - Eye Injuries.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16600340.001).
  • [ISSN] 0079-6107
  • [Journal-full-title] Progress in biophysics and molecular biology
  • [ISO-abbreviation] Prog. Biophys. Mol. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 52
  •  go-up   go-down


33. Mauldin EA, Credille KM, Dunstan RW, Casal ML: The clinical and morphologic features of nonepidermolytic ichthyosis in the golden retriever. Vet Pathol; 2008 Mar;45(2):174-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A scaling disorder specific to Golden Retriever dogs has been recognized by both dermatologists and pathologists, but to date has not been well characterized.
  • All affected dogs had retained and convoluted membranes with crystalline structures in the stratum corneum.
  • This unique hyperkeratotic/scaling disorder in Golden Retrievers has distinctive clinical, histologic, and ultrastructural features, which are consistent with a primary cornification defect.

  • SciCrunch. OMIA - Online Mendelian Inheritance in Animals: Data: Gene Expression .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comp Pathol. 2000 May;122(4):307-11 [10805985.001]
  • [Cites] Nat Biotechnol. 2001 Mar;19(3):225-30 [11231554.001]
  • [Cites] J Investig Dermatol Symp Proc. 1998 Aug;3(2):87-100 [9734820.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):687-90 [9435253.001]
  • [Cites] J Hered. 1997 Nov-Dec;88(6):513-7 [9419891.001]
  • [Cites] J Small Anim Pract. 2006 Sep;47(9):524-8 [16961470.001]
  • [Cites] Br J Dermatol. 2005 Jul;153(1):51-8 [16029326.001]
  • [Cites] Can Vet J. 2004 Oct;45(10):872, 874 [15532893.001]
  • [Cites] Cytogenet Cell Genet. 2001;93(1-2):73-6 [11474183.001]
  • [Cites] Am J Clin Dermatol. 2003;4(2):81-95 [12553849.001]
  • [Cites] Clin Exp Dermatol. 2003 May;28(3):235-40 [12780701.001]
  • [Cites] Hum Mol Genet. 2003 Sep 15;12(18):2369-78 [12915478.001]
  • [Cites] J Comp Pathol. 2004 May;130(4):246-54 [15053927.001]
  • [Cites] J Am Vet Med Assoc. 1976 Dec 15;169(12):1313-6 [1002598.001]
  • [Cites] Ann Hum Genet. 1979 May;42(4):507-12 [475337.001]
  • [Cites] Br Vet J. 1985 Jan-Feb;141(1):1-8 [3995245.001]
  • [Cites] Vestn Dermatol Venerol. 1989;(6):17-20 [2588785.001]
  • [Cites] J Invest Dermatol. 1994 Nov;103(5 Suppl):6S-12S [7525739.001]
  • [Cites] J Cell Biol. 1996 Jun;133(6):1367-82 [8682871.001]
  • (PMID = 18424829.001).
  • [ISSN] 0300-9858
  • [Journal-full-title] Veterinary pathology
  • [ISO-abbreviation] Vet. Pathol.
  • [Language] ENG
  • [Grant] United States / NCRR NIH HHS / RR / P40 RR002512; United States / NCRR NIH HHS / RR / P40 RR002512-27; United States / NCRR NIH HHS / RR / RR 02512
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS368076; NLM/ PMC3334879
  •  go-up   go-down


34. Kessner D, Kiselev MA, Hauss T, Dante S, Wartewig S, Neubert RH: Localisation of partially deuterated cholesterol in quaternary SC lipid model membranes: a neutron diffraction study. Eur Biophys J; 2008 Jul;37(6):1051-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This letter presents our first results in using the benefit of selective deuteration in neutron diffraction studies on stratum corneum (SC) lipid model systems.

  • MedlinePlus Health Information. consumer health - Cholesterol.
  • Hazardous Substances Data Bank. CHOLESTEROL .
  • Hazardous Substances Data Bank. DEUTERIUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Annu Rev Biophys Bioeng. 1972;1:529-52 [4567759.001]
  • [Cites] J Control Release. 1998 Mar 31;52(3):271-80 [9743447.001]
  • [Cites] Biophys J. 1995 Oct;69(4):1424-8 [8534812.001]
  • [Cites] J Invest Dermatol. 1983 Jun;80 Suppl:44s-49s [6189923.001]
  • [Cites] Chem Phys Lipids. 2005 Jan;133(1):89-102 [15589229.001]
  • [Cites] J Mol Biol. 1979 Oct 9;133(4):469-500 [537057.001]
  • [Cites] Biochim Biophys Acta. 2003 Mar 10;1610(2):187-97 [12648773.001]
  • [Cites] Biophys J. 2002 Jan;82(1 Pt 1):285-98 [11751316.001]
  • [Cites] Eur Biophys J. 2005 Nov;34(8):1030-40 [16032423.001]
  • [Cites] Biochim Biophys Acta. 2000 Nov 10;1469(3):159-95 [11063882.001]
  • [Cites] J Control Release. 2000 Jan 3;63(1-2):213-26 [10640594.001]
  • [Cites] Biophys J. 2003 Sep;85(3):1675-81 [12944282.001]
  • [Cites] Biochim Biophys Acta. 1996 Mar 15;1289(2):209-16 [8600975.001]
  • [Cites] Biochim Biophys Acta. 1999 Jul 15;1419(2):127-36 [10407065.001]
  • [Cites] Biochim Biophys Acta. 1974 Jul 12;356(1):1-7 [4841662.001]
  • [Cites] Biophys J. 1991 Jan;59(1):162-73 [2015381.001]
  • [Cites] Skin Pharmacol Physiol. 2008;21(2):58-74 [18187965.001]
  • [Cites] Biochim Biophys Acta. 1999 Feb 4;1417(1):89-100 [10076038.001]
  • [Cites] Chem Phys Lipids. 1998 Feb;91(2):85-96 [9569614.001]
  • [Cites] Biochim Biophys Acta. 2004 Aug 30;1664(2):132-40 [15328045.001]
  • [Cites] J Mol Biol. 1976 Jan 25;100(3):359-78 [943549.001]
  • (PMID = 18214463.001).
  • [ISSN] 0175-7571
  • [Journal-full-title] European biophysics journal : EBJ
  • [ISO-abbreviation] Eur. Biophys. J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Lipid Bilayers; 97C5T2UQ7J / Cholesterol; AR09D82C7G / Deuterium
  •  go-up   go-down


35. Yin HX, Huang ZF, Wang ZC, Liu ZH, Li Y, Zhu PP: [Application research of DEI technique based on synchrotron X-ray source in imaging rabbit eyeball in vitro]. Zhonghua Yi Xue Za Zhi; 2010 Mar 23;90(11):777-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULT: DEI image showed clearly the fine structures of the rabbit eyeball, such as the transparent cornea, the sclera, the ciliaris, and the ciliary body.
  • [MeSH-major] Cornea / radiography. Eye / radiography. X-Ray Diffraction / methods

  • MedlinePlus Health Information. consumer health - Eye Care.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20627026.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


36. Xhauflaire G, Uhoda E, Rakic JM: [Eye and ultraviolet light]. Rev Med Liege; 2005;60 Suppl 1:99-102
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All the ocular structures, from cornea to retinal layer, can be damaged by exposure to the light radiations.

  • MedlinePlus Health Information. consumer health - Eye Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15909561.001).
  • [ISSN] 0370-629X
  • [Journal-full-title] Revue médicale de Liège
  • [ISO-abbreviation] Rev Med Liege
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Belgium
  • [Number-of-references] 26
  •  go-up   go-down


37. He J, Bazan NG, Bazan HE: Mapping the entire human corneal nerve architecture. Exp Eye Res; 2010 Oct;91(4):513-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mapping the entire human corneal nerve architecture.
  • We developed an approach to generate a three-dimensional map that facilitates the assessment of epithelial nerve density in different corneal areas to define aging and gender influence on human corneal nerve architecture.
  • Corneal nerves were stained and consecutive images acquired with a fluorescence microscope, recorded at the same plane, and merged for viewing the complete epithelial and stromal nerve architecture.
  • After whole mount examination, the same cornea was also used for transection.
  • Stromal nerves entered the cornea in a radial pattern, subsequently dividing into smaller branches.
  • No differences were observed between nerve densities in the four corneal quadrants.
  • Epithelial nerve density and terminal numbers were higher in the center of the cornea, rather than the periphery.
  • The modified technique of tissue preparation used for this study allowed for observation of new nerve structure features and, for the first time, provided a complete view of the human corneal nerve architecture.

  • MedlinePlus Health Information. consumer health - Seniors' Health.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ophthalmology. 2003 May;110(5):1023-9; discussion 1029-30 [12750107.001]
  • [Cites] Exp Eye Res. 2003 May;76(5):521-42 [12697417.001]
  • [Cites] Medicina (Kaunas). 2003;39(10):955-9 [14578637.001]
  • [Cites] Exp Eye Res. 2004 Mar;78(3):513-25 [15106930.001]
  • [Cites] Ophthalmologica. 2004 Sep-Oct;218(5):350-5 [15334017.001]
  • [Cites] Am J Optom Arch Am Acad Optom. 1969 Apr;46(4):261-5 [5253423.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1977 Mar;16(3):240-2 [844979.001]
  • [Cites] Atherosclerosis. 1981 Aug-Sep;40(1):91-8 [7284055.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1982;218(1):14-20 [7056476.001]
  • [Cites] Ophthalmic Res. 1984;16(3):139-44 [6472793.001]
  • [Cites] Acta Ophthalmol Suppl. 1989;192:80-90 [2573227.001]
  • [Cites] Br J Ophthalmol. 1993 Jun;77(6):339-43 [8318479.001]
  • [Cites] Ophthalmology. 1995 Jan;102(1):33-41 [7831039.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1996 Mar;37(4):476-88 [8595948.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1997 Apr;38(5):985-94 [9112994.001]
  • [Cites] Am J Ophthalmol. 1999 May;127(5):497-504 [10334340.001]
  • [Cites] Cornea. 2005 Aug;24(6):705-9 [16015090.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3121-7 [16123410.001]
  • [Cites] Ophthalmologica. 2005 Sep-Oct;219(5):276-80 [16123553.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2005 Oct;243(10):1056-61 [15856272.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4485-8 [16303938.001]
  • [Cites] J Cataract Refract Surg. 2005 Oct;31(10):1881-7 [16338555.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2007 Jan;48(1):173-81 [17197530.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2007 Apr;245(4):569-75 [16941142.001]
  • [Cites] Ocul Surf. 2007 Apr;5(2):93-107 [17508117.001]
  • [Cites] J Cataract Refract Surg. 2007 Jul;33(7):1190-4 [17586374.001]
  • [Cites] J Cataract Refract Surg. 2007 Sep;33(9):1515-21 [17720064.001]
  • [Cites] Exp Eye Res. 2008 Jun;86(6):879-85 [18436208.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4801-7 [18614801.001]
  • [Cites] Nat Rev Immunol. 2008 Dec;8(12):935-47 [19029989.001]
  • [Cites] Cornea. 2009 May;28(4):401-7 [19411958.001]
  • [Cites] Br J Ophthalmol. 2009 Jul;93(7):853-60 [19019923.001]
  • [Cites] Mol Vis. 2009;15:1456-62 [19649162.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2010 Feb;51(2):804-10 [19797230.001]
  • [Cites] Exp Eye Res. 2010 Apr;90(4):478-92 [20036654.001]
  • [Cites] Br J Ophthalmol. 2010 Jun;94(6):784-9 [19889832.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2000 Feb;41(2):369-76 [10670464.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2138-47 [10892855.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2000 Sep;41(10):2915-21 [10967045.001]
  • [Cites] J Cataract Refract Surg. 2001 Mar;27(3):370-3 [11255047.001]
  • [Cites] Cornea. 2001 May;20(4):374-84 [11333324.001]
  • [Cites] Ophthalmology. 2001 Jul;108(7):1230-5 [11425680.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2002 Mar;43(3):639-46 [11867578.001]
  • [Cites] Clin Experiment Ophthalmol. 2002 Jun;30(3):187-90 [12010212.001]
  • [Cites] Prog Retin Eye Res. 2002 Mar;21(2):169-224 [12062534.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2002 Dec;43(12):3660-4 [12454033.001]
  • [Cites] Diabetologia. 2003 May;46(5):683-8 [12739016.001]
  • (PMID = 20650270.001).
  • [ISSN] 1096-0007
  • [Journal-full-title] Experimental eye research
  • [ISO-abbreviation] Exp. Eye Res.
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / R01 EY019465; United States / NEI NIH HHS / EY / R01EY019465
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS224437; NLM/ PMC2939211
  •  go-up   go-down


38. Ma X, Shimmura S, Miyashita H, Yoshida S, Kubota M, Kawakita T, Tsubota K: Long-term culture and growth kinetics of murine corneal epithelial cells expanded from single corneas. Invest Ophthalmol Vis Sci; 2009 Jun;50(6):2716-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term culture and growth kinetics of murine corneal epithelial cells expanded from single corneas.
  • PURPOSE: To develop a reproducible procedure for the long-term culture of corneal epithelial cells from a single mouse cornea.
  • METHODS: Corneal limbal explants of C57BL6/J mice were cultured in serum-free, low-Ca(2+) medium supplemented with EGF and cholera toxin.
  • RESULTS: Thirty of 32 (93.8%) corneal explants were successfully subcultured to P1.
  • CONCLUSIONS: With this procedure, corneal epithelial cells from a single cornea can be cultured long term and can retain the potential to differentiate and stratify.
  • This procedure can be a powerful tool for studies that require comparison of corneal epithelial cells from normal and transgenic mice in vitro.
  • [MeSH-major] Cell Culture Techniques. Epithelium, Corneal / cytology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19218612.001).
  • [ISSN] 1552-5783
  • [Journal-full-title] Investigative ophthalmology & visual science
  • [ISO-abbreviation] Invest. Ophthalmol. Vis. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Culture Media, Serum-Free; 0 / Keratins, Type I; 0 / Phosphoproteins; 0 / Protein Precursors; 0 / RNA, Messenger; 0 / Trans-Activators; 0 / Trp63 protein, mouse; 60108-77-2 / involucrin
  •  go-up   go-down


39. Chastang P, Hoang-Xuan T: [Femtosecond laser-assisted keratoplasties]. J Fr Ophtalmol; 2008 Nov;31(9):921-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This is not surprising when one knows that femtosecond lasers can cut corneal tissue in all directions with micrometric accuracy.
  • Lamellar dissection of the cornea is very facilitated with femtosecond laser because it is quicker and more reproducible.
  • [MeSH-major] Corneal Transplantation / methods. Laser Therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19107065.001).
  • [ISSN] 1773-0597
  • [Journal-full-title] Journal français d'ophtalmologie
  • [ISO-abbreviation] J Fr Ophtalmol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


40. van de Kraats J, van Norren D: Optical density of the aging human ocular media in the visible and the UV. J Opt Soc Am A Opt Image Sci Vis; 2007 Jul;24(7):1842-57
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Five templates were derived to provide an adequate description of the spectra from 300 to 700 nm for the lens, cornea, aqueous, and vitreous.

  • MedlinePlus Health Information. consumer health - Seniors' Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17728807.001).
  • [ISSN] 1084-7529
  • [Journal-full-title] Journal of the Optical Society of America. A, Optics, image science, and vision
  • [ISO-abbreviation] J Opt Soc Am A Opt Image Sci Vis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


41. Sheppard J, Hayes S, Boote C, Votruba M, Meek KM: Changes in corneal collagen architecture during mouse postnatal development. Invest Ophthalmol Vis Sci; 2010 Jun;51(6):2936-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Changes in corneal collagen architecture during mouse postnatal development.
  • PURPOSE: To characterize changes in corneal collagen arrangement during mouse postnatal development.
  • These were analyzed to produce measurements of the average separation distance between corneal collagen fibrils.
  • Changes in the predominant orientation of corneal collagen and its relative distribution during the same developmental period were determined using wide-angle X-ray scatter data collected at 0.2-mm intervals over the entire cornea and limbal region of each specimen.
  • After eye opening at day 12, collagen alignment gradually increased in the peripheral cornea and limbus.
  • By day 28, an annulus of highly aligned collagen surrounded the cornea.
  • CONCLUSIONS: Changes in corneal thickness before and after eye opening are not caused by widespread alterations in the collagen fibrillar array but are more likely caused by expansion and contraction of regions devoid of regularly arranged collagen.
  • The postnatal development of a corneal annulus of collagen, thought to play a role in stabilizing the curvature of the cornea, may be triggered by visual factors.
  • [MeSH-major] Collagen / analysis. Cornea / chemistry. Cornea / growth & development

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20089872.001).
  • [ISSN] 1552-5783
  • [Journal-full-title] Investigative ophthalmology & visual science
  • [ISO-abbreviation] Invest. Ophthalmol. Vis. Sci.
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / G0500790; United Kingdom / Medical Research Council / / G0600755
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 9007-34-5 / Collagen
  •  go-up   go-down


42. Estey T, Piatigorsky J, Lassen N, Vasiliou V: ALDH3A1: a corneal crystallin with diverse functions. Exp Eye Res; 2007 Jan;84(1):3-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] ALDH3A1: a corneal crystallin with diverse functions.
  • Aldehyde dehydrogenase 3A1 (ALDH3A1) comprises a surprisingly high proportion (5-50% depending on species) of the water-soluble protein of the mammalian cornea, but is present little if at all in the cornea of other species.
  • Mounting experimental evidence demonstrates that this abundant corneal protein plays an important role in the protection of ocular structures against oxidative damage.
  • Corneal ALDH3A1 appears to protect against UV-induced oxidative stress through a variety of biological functions such as the metabolism of toxic aldehydes produced during the peroxidation of cellular lipids, the generation of the antioxidant NADPH, the direct absorption of UV-light, the scavenging of reactive oxygen species (ROS), and the possession of chaperone-like activity.
  • With analogies to the abundant, multifunctional, and taxon-specific lens crystallins, mammalian ALDH3A1 has been considered a corneal crystallin, suggesting that it may contribute to the optical properties of the cornea as well.
  • Taken together, the multiple roles of ALDH3A1 against oxidative stress in addition to its contributions to the optical properties of the cornea are consistent with the idea that this specialized protein performs diverse biological functions as do the lens crystallins.
  • [MeSH-major] Aldehyde Dehydrogenase / physiology. Cornea / enzymology. Eye Proteins / physiology

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16797007.001).
  • [ISSN] 0014-4835
  • [Journal-full-title] Experimental eye research
  • [ISO-abbreviation] Exp. Eye Res.
  • [Language] eng
  • [Grant] United States / NEI NIH HHS / EY / R01 EY11490
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / Eye Proteins; 0 / Guanine Nucleotide Exchange Factors; 0 / Nuclear Proteins; 0 / RCC1 protein, human; EC 1.2.1.3 / ALDH3A1 protein, human; EC 1.2.1.3 / Aldehyde Dehydrogenase
  • [Number-of-references] 141
  •  go-up   go-down


43. Wohlrab J, Klapperstück T, Reinhardt HW, Albrecht M: Interaction of epicutaneously applied lipids with stratum corneum depends on the presence of either emulsifiers or hydrogenated phosphatidylcholine. Skin Pharmacol Physiol; 2010;23(6):298-305
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Interaction of epicutaneously applied lipids with stratum corneum depends on the presence of either emulsifiers or hydrogenated phosphatidylcholine.
  • The barrier function of the stratum corneum (SC) significantly determines the interaction of epicutaneously applied substances with the skin organ.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 S. Karger AG, Basel.
  • (PMID = 20523109.001).
  • [ISSN] 1660-5535
  • [Journal-full-title] Skin pharmacology and physiology
  • [ISO-abbreviation] Skin Pharmacol Physiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Emulsifying Agents; 0 / Fatty Acids; 0 / Fluorescent Dyes; 0 / Glycerides; 0 / Glycolipids; 0 / Lipid Bilayers; 0 / Lipids; 0 / Membrane Lipids; 0 / Phosphatidylcholines; 0 / Polysorbates; 0 / cetearyl glucoside; 30IQX730WE / Polyethylene Glycols; 7QWM220FJH / Squalene
  •  go-up   go-down


44. Jonasova K, Kozmik Z: Eye evolution: lens and cornea as an upgrade of animal visual system. Semin Cell Dev Biol; 2008 Apr;19(2):71-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Eye evolution: lens and cornea as an upgrade of animal visual system.
  • It is apparent that such an upgrade of animal visual system has originated numerous times during evolution since many distinct strategies to enhance light refraction through the use of lens and cornea have been utilized.
  • [MeSH-major] Biological Evolution. Cornea / physiology. Lens, Crystalline / physiology. Ocular Physiological Phenomena. Vision, Ocular / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18035562.001).
  • [ISSN] 1084-9521
  • [Journal-full-title] Seminars in cell & developmental biology
  • [ISO-abbreviation] Semin. Cell Dev. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Crystallins; 0 / Paired Box Transcription Factors
  • [Number-of-references] 107
  •  go-up   go-down


46. Wu F, Lee S, Schumacher M, Jun A, Chakravarti S: Differential gene expression patterns of the developing and adult mouse cornea compared to the lens and tendon. Exp Eye Res; 2008 Sep;87(3):214-25
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential gene expression patterns of the developing and adult mouse cornea compared to the lens and tendon.
  • The cornea continues to mature after birth to develop a fully functional, refractive and protective barrier tissue.
  • Here we investigated the complex biological events underlying this process by profiling global genome-wide gene expression patterns of the immature postnatal day 10 and 7-week old adult mouse cornea.
  • The lens and tendon were included in the study to increase the specificity of genes identified as upregulated in the corneal samples.
  • Notable similarities in gene expression between the cornea and the tendon were in the mesenchymal extracellular matrix collagen (types I, III, V, VI) and proteoglycan (lumican, decorin and biglycan) genes.
  • Expression similarities in the cornea and lens were limited to certain epithelial genes and the crystallins.
  • Approximately 76 genes were over expressed in the cornea samples that showed basal expression levels in the lens and tendon.
  • Thirty-two of these were novel with no known functions in the cornea.
  • Direct comparison of the cornea of two ages showed selective upregulation of 50 and 12 genes in the P10 and adult cornea, respectively.
  • Of the upregulated P10 genes several encode extracellular matrix collagens and proteoglycans that are stable components of the adult cornea and their high transcriptional activity at P10 indicate a period of actie corneal growth and matrix deposition in the young cornea.
  • Much less is known about the genes selectively over expressed in the adult cornea; some relate to immune response and innervations (Npy), and possibly to electron transport (Cyp24a1, Cyp2f2) and others of yet unknown functions in the cornea (Rgs10, Psmb8, Xlr4).
  • This study detected expression of genes with known functions in the cornea, providing additional validation of the microarray experiments.
  • Importantly, it identified several novel genes whose functions have not been investigated in the cornea.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1054-62 [10752941.001]
  • [Cites] Results Probl Cell Differ. 2000;31:1-14 [10929398.001]
  • [Cites] Mol Cell Biol. 2000 Dec;20(23):8903-15 [11073990.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):31-6 [11134512.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2002 Jan;43(1):72-81 [11773015.001]
  • [Cites] Exp Eye Res. 2001 Oct;73(4):411-9 [11825014.001]
  • [Cites] Vet Ophthalmol. 2001 Dec;4(4):267-72 [11906662.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1772-82 [12036978.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2002 Sep;43(9):2897-904 [12202508.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2003 Feb;44(2):548-57 [12556382.001]
  • [Cites] Vet Ophthalmol. 2003 Mar;6(1):19-22 [12641838.001]
  • [Cites] Exp Eye Res. 2003 May;76(5):521-42 [12697417.001]
  • [Cites] Exp Mol Pathol. 2003 Apr;74(2):106-12 [12710941.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2004 Feb;45(2):429-40 [14744882.001]
  • [Cites] Exp Eye Res. 2004 Mar;78(3):447-56 [15106924.001]
  • [Cites] Mol Cell Proteomics. 2004 Jul;3(7):660-74 [15054125.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2767-77 [15277503.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3475-84 [15452052.001]
  • [Cites] Anat Rec. 1970 Sep;168(1):105-25 [5469558.001]
  • [Cites] Monogr Dev Biol. 1969;1:1-144 [5407672.001]
  • [Cites] J Physiol. 1974 Sep;241(3):647-75 [4215880.001]
  • [Cites] Int Rev Cytol. 1980;63:263-322 [395131.001]
  • [Cites] Acta Ophthalmol (Copenh). 1991 Apr;69(2):247-50 [1872145.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1996 Jul;37(8):1566-75 [8675399.001]
  • [Cites] Eur J Cell Biol. 1997 Apr;72(4):352-61 [9127735.001]
  • [Cites] Prog Retin Eye Res. 1998 Apr;17(2):145-74 [9695791.001]
  • [Cites] J Cell Sci. 1999 Mar;112 ( Pt 5):613-22 [9973596.001]
  • [Cites] J Cell Biol. 1999 Jul 12;146(1):255-64 [10402475.001]
  • [Cites] J Physiol. 1957 Apr 30;136(2):263-86 [13429485.001]
  • [Cites] Exp Eye Res. 2005 Nov;81(5):570-80 [15950220.001]
  • [Cites] Exp Eye Res. 2006 Feb;82(2):183-4 [16360151.001]
  • [Cites] Br J Ophthalmol. 2007 Jan;91(1):94-9 [16956910.001]
  • [Cites] J Cell Biochem. 2007 Jun 1;101(3):695-711 [17226767.001]
  • [Cites] Dev Biol. 2007 Jun 15;306(2):750-9 [17499699.001]
  • [Cites] Proteomics. 2007 Sep;7(17):3194-206 [17676663.001]
  • [Cites] Stem Cells Dev. 2007 Oct;16(5):733-45 [17999595.001]
  • [Cites] Exp Eye Res. 2008 Mar;86(3):506-11 [18237730.001]
  • [Cites] Circ Res. 2008 Apr 11;102(7):752-60 [18296617.001]
  • (PMID = 18582462.001).
  • [ISSN] 1096-0007
  • [Journal-full-title] Experimental eye research
  • [ISO-abbreviation] Exp. Eye Res.
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / EY011654-11; United States / NEI NIH HHS / EY / R56 EY011654; United States / NEI NIH HHS / EY / R01 EY011654; United States / NEI NIH HHS / EY / EY011654-14; United States / NEI NIH HHS / EY / R01 EY011654-11; United States / NEI NIH HHS / EY / EY11654; United States / NEI NIH HHS / EY / R01 EY011654-12A1; United States / NEI NIH HHS / EY / R01 EY011654-14; United States / NEI NIH HHS / EY / EY011654-12A1
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Extracellular Matrix Proteins; 0 / Eye Proteins
  • [Other-IDs] NLM/ NIHMS70424; NLM/ PMC3043597
  •  go-up   go-down


47. Meyer L, Bednarz J, Müller-Goymann CC, Reichl S: [Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies]. Ophthalmologe; 2005 Oct;102(10):971-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies].
  • [Transliterated title] Esteraseaktivität eines organotypischen humanen Kornea-Konstrukts (HCC) als In-vitro-Modell für Permeationsuntersuchungen Originalien.
  • Organotypic cornea equivalents are used as in vitro models for permeation studies.
  • The esterase activity of three corneal human cell lines (epithelial, stromal, endothelial cells) as well as of excised porcine cornea, human donor cornea and human cornea construct (HCC) was investigated and compared.
  • Hydrocortisone acetate permeation across porcine cornea, human donor cornea and HCC was studied in vitro using Franz-diffusion cells.
  • Corneal epithelial cells showed the highest esterase activity and only small differences to keratocytes and endothelial cells were detectable.
  • The permeation barrier properties of the different corneal tissues were very similar in the case of HCA permeation whereas HCA metabolism rates were in the ranking order of porcine cornea > HCC > human donor cornea.
  • [MeSH-major] Cornea / metabolism. Esterases / metabolism. Ophthalmic Solutions / pharmacokinetics
  • [MeSH-minor] Aged. Animals. Biological Availability. Cells, Cultured. Corneal Stroma / drug effects. Corneal Stroma / enzymology. Corneal Stroma / metabolism. Endothelium, Corneal / cytology. Endothelium, Corneal / drug effects. Endothelium, Corneal / metabolism. Epithelium, Corneal / cytology. Epithelium, Corneal / drug effects. Epithelium, Corneal / enzymology. Epithelium, Corneal / metabolism. Humans. Hydrocortisone / analogs & derivatives. Hydrocortisone / metabolism. Microscopy, Phase-Contrast. Middle Aged. Organ Culture Techniques. Permeability. Prodrugs / pharmacokinetics. Swine. Time Factors. Tissue Donors

  • Genetic Alliance. consumer health - Hepatocellular carcinoma, adult.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2942-8 [11687540.001]
  • [Cites] In Vitro Cell Dev Biol Anim. 1999 Oct;35(9):515-26 [10548433.001]
  • [Cites] Br J Ophthalmol. 2004 Apr;88(4):560-5 [15031177.001]
  • [Cites] Science. 1999 Dec 10;286(5447):2169-72 [10591651.001]
  • [Cites] Acta Ophthalmol Scand. 2000 Apr;78(2):130-6 [10794243.001]
  • [Cites] Eur J Pharm Sci. 2003 Sep;20(1):99-106 [13678798.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1993 Jun;34(7):2316-24 [7685009.001]
  • [Cites] Am J Ophthalmol. 1978 Mar;85(3):383-6 [655217.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1999 May;40(6):1091-101 [10235542.001]
  • [Cites] Ophthalmic Res. 2001 Jan-Feb;33(1):1-6 [11114598.001]
  • [Cites] J Ocul Pharmacol Ther. 2002 Oct;18(5):455-68 [12419096.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1995 Mar;36(3):614-21 [7534282.001]
  • [Cites] Ophthalmic Res. 1993;25(1):46-51 [8446367.001]
  • [Cites] Curr Eye Res. 1998 Feb;17(2):125-31 [9523089.001]
  • [Cites] Ophthalmologe. 2001 Sep;98(9):853-8 [11594225.001]
  • [Cites] J Pharm Sci. 1999 Feb;88(2):180-4 [9950635.001]
  • [Cites] J Ocul Pharmacol. 1985 Fall;1(3):309-26 [3916851.001]
  • [Cites] Pharm Res. 2002 Aug;19(8):1194-202 [12240946.001]
  • [Cites] J Pharm Sci. 2001 Oct;90(10):1505-15 [11745709.001]
  • [Cites] J Ocul Pharmacol Ther. 2001 Apr;17 (2):159-72 [11324983.001]
  • [Cites] J Pharm Sci. 1983 Mar;72(3):239-44 [6842375.001]
  • [Cites] Pharm Res. 2000 Jun;17(6):670-6 [10955839.001]
  • [Cites] Eur J Pharm Biopharm. 2005 Jul;60(2):305-8 [15939241.001]
  • [Cites] Biopharm Drug Dispos. 1982 Oct-Dec;3(4):291-300 [7159685.001]
  • [Cites] Eur J Pharm Biopharm. 2001 Mar;51(2):119-25 [11226818.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1994 Mar;232(3):182-91 [8188069.001]
  • [Cites] J Ocul Pharmacol Ther. 2002 Dec;18(6):535-48 [12537680.001]
  • [Cites] Ophthalmologe. 2003 Sep;100(9):696-701 [14504893.001]
  • (PMID = 15785910.001).
  • [ISSN] 0941-293X
  • [Journal-full-title] Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
  • [ISO-abbreviation] Ophthalmologe
  • [Language] ger
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Ophthalmic Solutions; 0 / Prodrugs; 3X7931PO74 / hydrocortisone acetate; EC 3.1.- / Esterases; WI4X0X7BPJ / Hydrocortisone
  •  go-up   go-down


48. Tzu JH, Desai NR, Akpek EK: Use of a microvascular clip for iris fixation of an intraocular lens: a laboratory model. Arch Ophthalmol; 2010 Jan;128(1):114-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Also, this technique is easier than suturing and may potentially serve as another tool in a cornea surgeon's armamentarium.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20065227.001).
  • [ISSN] 1538-3601
  • [Journal-full-title] Archives of ophthalmology (Chicago, Ill. : 1960)
  • [ISO-abbreviation] Arch. Ophthalmol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Messmer EM: [Ocular allergies]. Ophthalmologe; 2005 May;102(5):527-43; quiz 544
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ocular allergy is a disease affecting the entire ocular surface including conjunctiva, lids, cornea, lacrimal gland and tear film.
  • [MeSH-minor] Adrenal Cortex Hormones / therapeutic use. Anti-Allergic Agents / therapeutic use. Anti-Inflammatory Agents, Non-Steroidal / therapeutic use. Desensitization, Immunologic. Diagnosis, Differential. Humans. Immunosuppressive Agents / therapeutic use. Plasmapheresis. Skin Tests

  • MedlinePlus Health Information. consumer health - Allergy.
  • MedlinePlus Health Information. consumer health - Eye Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Dermatol. 1999 Oct;26(10):658-65 [10554432.001]
  • [Cites] Mayo Clin Proc. 1992 Jun;67(6):557-65 [1359206.001]
  • [Cites] J Ocul Pharmacol Ther. 2003 Aug;19(4):315-24 [12964956.001]
  • [Cites] Allergy. 1994 Dec;49(10):808-15 [7709989.001]
  • [Cites] Cornea. 2004 Mar;23(2):194-200 [15075890.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4175-81 [11095612.001]
  • [Cites] Br J Ophthalmol. 2003 Oct;87(10):1206-11 [14507747.001]
  • [Cites] Clin Exp Allergy. 2004 Feb;34(2):201-6 [14987298.001]
  • [Cites] Ophthalmology. 1998 Sep;105(9):1715-20 [9754182.001]
  • [Cites] Pharmacotherapy. 1990;10(6 ( Pt 2)):30S-32S [2082310.001]
  • [Cites] Eye (Lond). 2004 Apr;18(4):345-51 [15069427.001]
  • [Cites] Am J Ophthalmol. 1996 Dec;122(6):825-9 [8956637.001]
  • [Cites] Clin Exp Allergy. 2002 Jun;32(6):814-7 [12047424.001]
  • [Cites] J Immunol. 1997 Aug 1;159(3):1140-9 [9233607.001]
  • [Cites] J Allergy Clin Immunol. 2000 Aug;106(2):253-9 [10932067.001]
  • [Cites] Ophthalmology. 1998 Apr;105(4):637-42 [9544637.001]
  • [Cites] Arch Ophthalmol. 2003 May;121(5):615-20 [12742837.001]
  • [Cites] Am J Ophthalmol. 1959 Feb;47(2):166-72 [13617386.001]
  • [Cites] Clin Exp Allergy. 1996 Jan;26(1):79-87 [8789546.001]
  • [Cites] Clin Ther. 2004 Jan;26(1):29-34 [14996515.001]
  • [Cites] Ophthalmologe. 2003 Mar;100(3):240-50; quiz 251 [12640555.001]
  • [Cites] Br J Ophthalmol. 1997 May;81(5):402-6 [9227207.001]
  • [Cites] Exp Eye Res. 1998 Nov;67(5):491-500 [9878210.001]
  • [Cites] Acta Ophthalmol Scand Suppl. 2000;(230):32-7 [11057347.001]
  • [Cites] Ophthalmology. 1990 Aug;97(8):992-1000 [1976238.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1999 Nov;40(12 ):3041-6 [10549671.001]
  • [Cites] Int J Immunopathol Pharmacol. 1999 Jan-Apr;12(3):133-137 [12783641.001]
  • [Cites] Ann Allergy Asthma Immunol. 2002 Apr;88(4 Suppl 1):23-9 [11991547.001]
  • [Cites] Ophthalmology. 2000 Dec;107(12 ):2158-61 [11097588.001]
  • [Cites] J Allergy Clin Immunol. 1987 Nov;80(5):711-6 [3680814.001]
  • [Cites] Ophthalmologe. 2002 Oct;99(10):761-7 [12376851.001]
  • [Cites] Int Ophthalmol Clin. 2003 Winter;43(1):33-9 [12544393.001]
  • [Cites] Ann Allergy Asthma Immunol. 2002 Sep;89(3):298-303 [12269651.001]
  • [Cites] Clin Exp Allergy. 2003 Dec;33(12):1675-80 [14656354.001]
  • [Cites] N Engl J Med. 1999 Dec 23;341(26):1966-73 [10607813.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1997 Sep;38(10):2161-4 [9331280.001]
  • [Cites] Trans Ophthalmol Soc U K. 1986;105 ( Pt 5):513-20 [3467503.001]
  • [Cites] Clin Exp Allergy. 1999 Sep;29(9):1214-22 [10469030.001]
  • [Cites] Br J Ophthalmol. 1998 Oct;82(10):1203-14 [9924312.001]
  • [Cites] Am J Ophthalmol. 2002 Dec;134(6):816-21 [12470748.001]
  • [Cites] Int Ophthalmol Clin. 2003 Winter;43(1):59-71 [12544395.001]
  • [Cites] Arch Dis Child. 1999 Sep;81(3):225-30 [10451395.001]
  • [Cites] Curr Eye Res. 2003 May;26(5):271-6 [12854054.001]
  • [Cites] Ophthalmology. 1997 Aug;104(8):1300-5 [9261317.001]
  • [Cites] Cornea. 2004 May;23(4):326-9 [15097124.001]
  • [Cites] Int Ophthalmol Clin. 2003 Winter;43(1):41-58 [12544394.001]
  • [Cites] Cornea. 1995 Nov;14(6):610-3 [8575184.001]
  • [Cites] Ophthalmology. 1980 Aug;87(8):812-4 [7443214.001]
  • [Cites] Am J Ophthalmol. 1996 Mar;121(3):243-9 [8597266.001]
  • [Cites] Eur J Ophthalmol. 2003 Aug-Sep;13(7):606-10 [14552593.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1998 Jun;39(7):1272-5 [9620090.001]
  • [Cites] Cornea. 1999 Nov;18(6):645-51 [10571292.001]
  • [Cites] Clin Exp Allergy. 1997 Apr;27(4):372-8 [9146929.001]
  • [Cites] Pediatr Allergy Immunol. 2001 Aug;12(4):208-15 [11555318.001]
  • [Cites] Int Ophthalmol Clin. 2003 Winter;43(1):9-25 [12544391.001]
  • [Cites] Br J Ophthalmol. 1977 Dec;61(12):761-4 [603783.001]
  • [Cites] J Allergy Clin Immunol. 1996 Sep;98(3):686-96 [8828547.001]
  • [Cites] Clin Ther. 2003 Jul;25(7):2070-84 [12946551.001]
  • [Cites] Trans Am Ophthalmol Soc. 1990;88:343-9; discussion 349-51 [2095029.001]
  • [Cites] Ophthalmologe. 2003 Oct;100(10):808-14 [14618353.001]
  • [Cites] Ophthalmology. 1988 Apr;95(4):444-7 [3174011.001]
  • [Cites] Dermatology. 2001;203(4):280-3 [11752812.001]
  • [Cites] Int Ophthalmol Clin. 2003 Winter;43(1):27-32 [12544392.001]
  • [Cites] Can J Ophthalmol. 1984 Feb;19(1):21-4 [6713265.001]
  • [Cites] J Allergy Clin Immunol. 1997 Dec;100(6 Pt 1):817-24 [9438492.001]
  • [Cites] Clin Exp Allergy. 2003 Mar;33(3):279-81 [12614438.001]
  • [Cites] Indian J Ophthalmol. 2003 Mar;51(1):79-80 [12701868.001]
  • [Cites] Curr Opin Allergy Clin Immunol. 2003 Oct;3(5):381-7 [14501439.001]
  • [Cites] Ophthalmologica. 2001 Jul-Aug;215(4):290-3 [11399937.001]
  • [Cites] Curr Opin Allergy Clin Immunol. 2004 Oct;4(5):431-4 [15349044.001]
  • [Cites] Can J Ophthalmol. 1999 Apr;34(2):88-92 [10321319.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3052-8 [12824251.001]
  • [Cites] Ophthalmology. 2000 Jun;107(6):1157-63 [10857837.001]
  • [Cites] Cornea. 2002 Mar;21(2 Suppl 1):S39-45 [11995809.001]
  • [Cites] Ophthalmology. 1998 Aug;105(8):1478-84 [9709761.001]
  • [Cites] J Allergy Clin Immunol. 2000 Nov;106(5):948-54 [11080719.001]
  • [Cites] Am J Ophthalmol. 1993 May 15;115(5):640-3 [8488918.001]
  • [Cites] J Clin Lab Anal. 2001;15(2):71-5 [11291108.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2002 Jan;43(1):58-62 [11773013.001]
  • [Cites] J Ocul Pharmacol Ther. 2003 Apr;19(2):153-9 [12804060.001]
  • [Cites] Curr Eye Res. 2001 Apr;22(4):253-7 [11462163.001]
  • [Cites] Ophthalmology. 2004 Mar;111(3):476-82 [15019322.001]
  • [Cites] J Refract Surg. 1995 Jan-Feb;11(1):31-5 [7641046.001]
  • [Cites] Am J Ophthalmol. 1983 Apr;95(4):502-5 [6573138.001]
  • [Cites] Curr Opin Allergy Clin Immunol. 2004 Oct;4(5):455-9 [15349048.001]
  • [Cites] Arch Ophthalmol. 1979 May;97(5):892-5 [444123.001]
  • [Cites] Allergy. 1995;50(21 Suppl):6-9; discussion 34-8 [7785749.001]
  • [Cites] J Allergy Clin Immunol. 2000 Dec;106(6):1019-32 [11112882.001]
  • [Cites] Ophthalmology. 1991 Feb;98(2):150-8 [2008272.001]
  • [Cites] Cornea. 2004 Aug;23(6):608-12 [15257001.001]
  • [Cites] Int Ophthalmol Clin. 2003 Winter;43(1):105-10 [12544399.001]
  • [Cites] Curr Opin Ophthalmol. 1998 Aug;9(4):54-8 [10387470.001]
  • [Cites] HNO. 1999 Jul;47(7):602-10 [10463112.001]
  • [Cites] Clin Allergy Immunol. 2002;17:337-88 [12113223.001]
  • [Cites] Eye (Lond). 1998;12 ( Pt 6):1001-6 [10326004.001]
  • [Cites] Int Ophthalmol Clin. 2003 Winter;43(1):1-7 [12544390.001]
  • [Cites] Eye Contact Lens. 2003 Jan;29(1 Suppl):S37-9; discussion S57-9, S192-4 [12772728.001]
  • [Cites] J Allergy Clin Immunol. 1997 Sep;100(3):283-7 [9314336.001]
  • [Cites] Ophthalmologe. 2005 Mar;102(3):293-300 [15616816.001]
  • [Cites] Clin Immunol. 1999 Nov;93(2):107-13 [10527686.001]
  • [Cites] Ophthalmology. 1991 Aug;98(8):1190-6 [1923355.001]
  • [Cites] Klin Monbl Augenheilkd. 1992 Sep;201(3):159-63 [1405394.001]
  • [Cites] J Cataract Refract Surg. 1999 Jan;25(1):96-9 [9888084.001]
  • [Cites] BMJ. 1994 Jun 18;308(6944):1591-6 [8025424.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1999 Feb;40(2):392-9 [9950598.001]
  • [Cites] Arch Ophthalmol. 2001 Oct;119(10):1512-7 [11594953.001]
  • [Cites] JAMA. 2001 Dec 19;286(23):2956-67 [11743836.001]
  • [Cites] Int Ophthalmol Clin. 2003 Winter;43(1):83-93 [12544397.001]
  • [Cites] Ophthalmology. 1995 Sep;102(9):1374-9 [9097776.001]
  • [Cites] Ann N Y Acad Sci. 1996 Oct 31;796:203-8 [8906227.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1995 Sep;36(10):2127-32 [7657550.001]
  • [Cites] Arch Ophthalmol. 1984 Aug;102(8):1198-9 [6466185.001]
  • [Cites] Arch Ophthalmol. 2001 Mar;119(3):338-42 [11231766.001]
  • [Cites] J Allergy Clin Immunol. 1999 Jun;103(6):1220-1 [10359913.001]
  • [Cites] Psychosom Med. 2003 Sep-Oct;65(5):816-23 [14508026.001]
  • [Cites] Ophthalmologe. 1999 Jul;96(7):473-88 [10479902.001]
  • [Cites] Br J Ophthalmol. 1996 Jun;80(6):556-60 [8759270.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1994 Jun;35(7):3051-6 [8206722.001]
  • [Cites] Curr Eye Res. 2003 Jun;26(6):319-25 [12868012.001]
  • [Cites] Clin Ther. 2003 Oct;25(10):2539-52 [14667955.001]
  • [Cites] J Immunol. 1991 Feb 15;146(4):1169-74 [1825106.001]
  • [Cites] J Allergy Clin Immunol. 1998 Nov;102(5):821-30 [9819300.001]
  • [Cites] Ophthalmology. 1995 Jun;102(6):985-93 [7777308.001]
  • [Cites] Am J Ophthalmol. 1983 May;95(5):704-5 [6846462.001]
  • [Cites] J Allergy Clin Immunol. 2004 May;113(5):832-6 [15131563.001]
  • [Cites] Ophthalmology. 1990 Jun;97(6):729-33 [2197589.001]
  • [Cites] Clin Exp Allergy. 2003 Mar;33(3):325-30 [12614446.001]
  • [Cites] Clin Exp Immunol. 1995 Nov;102(2):395-8 [7586697.001]
  • [Cites] Clin Exp Allergy. 1998 Dec;28 Suppl 6:8-14 [9988428.001]
  • [Cites] Clin Exp Optom. 2002 May;85(3):193-7 [12033982.001]
  • [Cites] J Allergy Clin Immunol. 2004 Feb;113(2):355-8 [14767456.001]
  • [Cites] Br J Ophthalmol. 2000 Nov;84(11):1228-32 [11049945.001]
  • [Cites] BMJ. 1992 Oct 17;305(6859):933-6 [1458075.001]
  • (PMID = 15806370.001).
  • [ISSN] 0941-293X
  • [Journal-full-title] Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
  • [ISO-abbreviation] Ophthalmologe
  • [Language] ger
  • [Publication-type] Comparative Study; English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones; 0 / Anti-Allergic Agents; 0 / Anti-Inflammatory Agents, Non-Steroidal; 0 / Immunosuppressive Agents
  • [Number-of-references] 133
  •  go-up   go-down


50. Zhong X, Chen X, Xie RZ, Yang J, Li S, Yang X, Gong X: Differences between overnight and long-term wear of orthokeratology contact lenses in corneal contour, thickness, and cell density. Cornea; 2009 Apr;28(3):271-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differences between overnight and long-term wear of orthokeratology contact lenses in corneal contour, thickness, and cell density.
  • PURPOSE: To investigate changes in corneal topography and morphology in human eyes wearing orthokeratology (OK) lenses for overnight and over a 5-year period.
  • Visual acuity, slit-lamp biomicroscopy, confocal microscopy, and corneal topography were assessed before and after lens wear.
  • RESULTS: Visual acuity was improved satisfactorily with flattening of the central cornea in both lens wear groups.
  • Corneal thickness increased extensively in the 1-night lens wear group but only paracentrally in the 5-year lens wear group.
  • Keratocyte density was reduced throughout the entire corneal thickness for the 2 groups.
  • CONCLUSIONS: Short-term and long-term OK lens wear can effectively correct myopia by flattening the cornea.
  • The flattened cornea in the short-term lens wear is mainly because of the thickening of the midperipheral cornea.
  • In the long-term lens wear, however, this change is associated with thickening of the midperipheral cornea and thinning of the central corneal epithelium.
  • [MeSH-major] Contact Lenses / utilization. Contact Lenses, Extended-Wear / utilization. Cornea / pathology. Corneal Topography. Myopia / therapy. Orthokeratologic Procedures

  • MedlinePlus Health Information. consumer health - Eye Wear.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19387227.001).
  • [ISSN] 1536-4798
  • [Journal-full-title] Cornea
  • [ISO-abbreviation] Cornea
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


51. Saika S, Ikeda K, Yamanaka O, Miyamoto T, Ohnishi Y, Sato M, Muragaki Y, Ooshima A, Nakajima Y, Kao WW, Flanders KC, Roberts AB: Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am J Pathol; 2005 May;166(5):1405-18
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali.
  • Damage to the cornea from chemical burns is a serious clinical problem that often leads to permanent visual impairment.
  • Because transforming growth factor (TGF)-beta has been implicated in the response to corneal injury, we evaluated the effects of altered TGF-beta signaling in a corneal alkali burn model using mice treated topically with an adenovirus (Ad) expressing inhibitory Smad7 and mice with a targeted deletion of the TGF-beta/activin signaling mediator Smad3.
  • Expression of exogenous Smad7 in burned corneal tissue resulted in reduced activation of Smad signaling and nuclear factor-kappaB signaling via RelA/p65.
  • Resurfacing of the burned cornea by conjunctival epithelium and its differentiation to cornea-like epithelium were both accelerated in Smad7-Ad-treated corneas with suppressed stromal ulceration, opacification, and neovascularization 20 days after injury.
  • Although acceleration of healing of the burned cornea was also observed in mice lacking Smad3, the effects on epithelial and stromal healing were less pronounced than those in corneas treated with Smad7.

  • MedlinePlus Health Information. consumer health - Corneal Disorders.
  • MedlinePlus Health Information. consumer health - Eye Care.
  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lab Invest. 2003 Dec;83(12):1689-707 [14691287.001]
  • [Cites] Am J Pathol. 2004 Feb;164(2):651-63 [14742269.001]
  • [Cites] J Biol Chem. 2004 Feb 6;279(6):3925-32 [14600158.001]
  • [Cites] Int J Exp Pathol. 2004 Apr;85(2):47-64 [15154911.001]
  • [Cites] Kidney Int. 2004 Aug;66(2):605-13 [15253713.001]
  • [Cites] J Immunol. 2004 Aug 1;173(3):2099-108 [15265946.001]
  • [Cites] Nat Rev Immunol. 2004 Aug;4(8):617-29 [15286728.001]
  • [Cites] J Immunol. 2004 Aug 15;173(4):2507-15 [15294966.001]
  • [Cites] Lab Invest. 2004 Oct;84(10):1259-70 [15258599.001]
  • [Cites] Curr Eye Res. 1998 Jan;17(1):79-87 [9472475.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1998 May;39(6):913-21 [9579471.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1998 Aug;39(9):1744-50 [9699566.001]
  • [Cites] J Cell Biol. 1998 Aug 10;142(3):873-81 [9700173.001]
  • [Cites] FEBS Lett. 1998 Sep 11;435(1):29-34 [9755853.001]
  • [Cites] Exp Eye Res. 1998 Nov;67(5):531-8 [9878215.001]
  • [Cites] J Clin Invest. 1999 Jan;103(1):73-80 [9884336.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1999 May;40(6):1112-23 [10235544.001]
  • [Cites] J Clin Invest. 1999 Jul;104(1):5-11 [10393693.001]
  • [Cites] Lab Invest. 2004 Oct;84(10):1245-58 [15273699.001]
  • [Cites] J Cell Biol. 1989 Feb;108(2):653-60 [2465297.001]
  • [Cites] Development. 1991 Sep;113(1):183-91 [1764993.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1993 Nov;34(12):3320-8 [8225867.001]
  • [Cites] Cornea. 1993 Sep;12(5):383-90 [8306658.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1995 Mar;36(3):614-21 [7534282.001]
  • [Cites] Blood. 1996 Apr 15;87(8):3336-43 [8605350.001]
  • [Cites] Differentiation. 1996 Mar;60(1):31-8 [8935926.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1996 Dec;37(13):2572-84 [8977471.001]
  • [Cites] Biochem Biophys Res Commun. 1999 Oct 22;264(2):561-7 [10529402.001]
  • [Cites] Nat Cell Biol. 1999 Sep;1(5):260-6 [10559937.001]
  • [Cites] J Biol Chem. 2000 Jan 28;275(4):2607-12 [10644720.001]
  • [Cites] Genes Dev. 2000 Jan 15;14(2):187-97 [10652273.001]
  • [Cites] EMBO J. 2000 Apr 17;19(8):1745-54 [10775259.001]
  • [Cites] Ophthalmology. 2000 May;107(5):980-9; discussion 990 [10811094.001]
  • [Cites] J Biol Chem. 2000 Sep 15;275(37):28937-46 [10874048.001]
  • [Cites] Int J Mol Med. 2000 Oct;6(4):391-407 [10998429.001]
  • [Cites] Am J Ophthalmol. 2000 Jul;130(1):134-7 [11004281.001]
  • [Cites] Ophthalmology. 2000 Oct;107(10):1829-35 [11013181.001]
  • [Cites] J Clin Invest. 2001 Jan;107(1):3-6 [11134170.001]
  • [Cites] J Clin Invest. 2001 Jan;107(1):7-11 [11134171.001]
  • [Cites] J Clin Invest. 2001 Jan;107(2):135-42 [11160126.001]
  • [Cites] Oncogene. 2001 Feb 15;20(7):879-84 [11314022.001]
  • [Cites] J Biol Chem. 2001 Apr 27;276(17):14344-9 [11278814.001]
  • [Cites] J Biol Chem. 2001 Jun 8;276(23):19945-53 [11262418.001]
  • [Cites] Hepatology. 2001 Jul;34(1):89-100 [11431738.001]
  • [Cites] Chest. 2001 Jul;120(1 Suppl):43S-47S [11451911.001]
  • [Cites] Am J Pathol. 2001 Aug;159(2):457-63 [11485904.001]
  • [Cites] J Clin Invest. 2001 Sep;108(6):807-16 [11560950.001]
  • [Cites] FEBS Lett. 2001 Nov 16;508(2):187-90 [11718713.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2002 Jan;43(1):72-81 [11773015.001]
  • [Cites] Dev Biol. 2001 Dec 15;240(2):419-32 [11784073.001]
  • [Cites] Am J Pathol. 2002 Mar;160(3):1057-68 [11891202.001]
  • [Cites] Cell. 1997 Jun 27;89(7):1165-73 [9215638.001]
  • [Cites] Nature. 1997 Oct 9;389(6651):631-5 [9335507.001]
  • [Cites] Am J Pathol. 2005 May;166(5):1393-403 [15855640.001]
  • [Cites] J Cell Physiol. 2002 Apr;191(1):1-16 [11920677.001]
  • [Cites] Prog Retin Eye Res. 2002 Jan;21(1):1-14 [11906808.001]
  • [Cites] Nat Rev Mol Cell Biol. 2002 May;3(5):349-63 [11988769.001]
  • [Cites] Immunol Lett. 2002 Jun 3;82(1-2):85-91 [12008039.001]
  • [Cites] Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):413-21 [12220554.001]
  • [Cites] Exp Eye Res. 2002 Dec;75(6):625-34 [12470964.001]
  • [Cites] Exp Eye Res. 2002 Dec;75(6):645-57 [12470966.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2003 Jan;44(1):117-23 [12506063.001]
  • [Cites] Exp Cell Res. 2003 Jan 15;282(2):90-100 [12531695.001]
  • [Cites] J Biol Chem. 2003 Feb 7;278(6):3751-61 [12446693.001]
  • [Cites] Virology. 2003 May 10;309(2):196-202 [12758167.001]
  • [Cites] J Am Soc Nephrol. 2003 Jun;14(6):1535-48 [12761254.001]
  • [Cites] Gastroenterology. 2003 Jul;125(1):178-91 [12851882.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10269-74 [12930890.001]
  • [Cites] Nature. 2003 Oct 9;425(6958):577-84 [14534577.001]
  • [Cites] Exp Eye Res. 2003 Dec;77(6):653-64 [14609553.001]
  • [Cites] J Clin Invest. 2003 Nov;112(10):1486-94 [14617750.001]
  • [Cites] Am J Pathol. 2003 Dec;163(6):2247-57 [14633599.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2004 Jan;45(1):100-9 [14691160.001]
  • (PMID = 15855641.001).
  • [ISSN] 0002-9440
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / R01 EY013755; United States / NEI NIH HHS / EY / EY 13755
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Alkalies; 0 / DNA-Binding Proteins; 0 / Growth Substances; 0 / NF-kappa B; 0 / Smad3 Protein; 0 / Smad3 protein, mouse; 0 / Smad7 Protein; 0 / Smad7 protein, mouse; 0 / Trans-Activators
  • [Other-IDs] NLM/ PMC1606395
  •  go-up   go-down


52. Lorenzini PF, Picoli SU: [Aerobic bacterial microbiota of the conjunctiva of cornea donors]. Arq Bras Oftalmol; 2007 Mar-Apr;70(2):229-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Aerobic bacterial microbiota of the conjunctiva of cornea donors].
  • [Transliterated title] Microbiota bacteriana aeróbia da conjuntiva de doadores de córnea.
  • PURPOSE: To determine aerobic bacterial microbiota of the conjunctiva of cornea donors and its patterns of susceptibility to antibiotics; verify the number of corneas used for transplant and the average time of preservation in solutions with gentamicin and streptomycin; trace the profile of donors and receptors of cornea.
  • METHODS: Clinical specimens were collected from the inferior bag of the conjunctiva of both eyes of 40 cornea donors.
  • RESULTS: The frequency of positive cultures of the conjunctiva of cornea donors was 72.5%, with Gram-positive totalling 81.6% and only 18.4% of the samples were identified as Gram-negative.
  • [MeSH-minor] Adolescent. Adult. Aged. Anti-Bacterial Agents / pharmacology. Brazil. Corneal Transplantation / standards. Corneal Transplantation / statistics & numerical data. Drug Resistance, Microbial. Gentamicins / pharmacology. Gram-Negative Bacteria / drug effects. Gram-Negative Bacteria / isolation & purification. Gram-Positive Bacteria / drug effects. Gram-Positive Bacteria / isolation & purification. Humans. Male. Microbial Sensitivity Tests / methods. Middle Aged. Streptomycin / pharmacology. Vancomycin / pharmacology

  • MedlinePlus Health Information. consumer health - Organ Donation.
  • Hazardous Substances Data Bank. Vancomycin .
  • Hazardous Substances Data Bank. STREPTOMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17589692.001).
  • [ISSN] 0004-2749
  • [Journal-full-title] Arquivos brasileiros de oftalmologia
  • [ISO-abbreviation] Arq Bras Oftalmol
  • [Language] por
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Gentamicins; 6Q205EH1VU / Vancomycin; Y45QSO73OB / Streptomycin
  •  go-up   go-down


53. Sumioka T, Ikeda K, Okada Y, Yamanaka O, Kitano A, Saika S: Inhibitory effect of blocking TGF-beta/Smad signal on injury-induced fibrosis of corneal endothelium. Mol Vis; 2008;14:2272-81
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inhibitory effect of blocking TGF-beta/Smad signal on injury-induced fibrosis of corneal endothelium.
  • PURPOSE: To understand the role of TGF-beta related signals in the repair of a corneal endothelium defect and also to evaluate the therapeutic effect of Smad7 gene transfer on injury induced fibrosis of the corneal endothelium in rats. METHODS:.
  • Blocks of central cornea (4 x 4 mm) were prepared.
  • The cornea was burned with topical 1 N NaOH (10 microl) three days later.
  • Inhibition of p38 and Erk but not c-Jun NH(2)-terminal kinase (JNK) and ALK5 signal (Smad) retarded such cell spreading. (2) Adenoviral Smad7 overexpression suppressed fibrogenic reaction of the endothelium of an alkali-burned cornea as evaluated by immunohistochemistry for phospho-Smad2, collagen I, and alpha-smooth muscle actin, a marker for endothelial-mesenchymal transition (EnMT), and by electron microscopy.
  • CONCLUSIONS: Inhibition of Smad and JNK signals do not affect corneal endothelium defect repair.
  • Inhibition of Smad suppresses fibrogenic reaction via EnMT of corneal endothelium in vivo.
  • [MeSH-major] Endothelium, Corneal / drug effects. Endothelium, Corneal / pathology. Signal Transduction / drug effects. Smad Proteins / antagonists & inhibitors. Transforming Growth Factor beta1 / antagonists & inhibitors

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Am Thorac Soc. 2006 Jun;3(4):377-82 [16738204.001]
  • [Cites] Endocr Metab Immune Disord Drug Targets. 2008 Mar;8(1):69-76 [18393925.001]
  • [Cites] Curr Opin Cell Biol. 2007 Apr;19(2):176-84 [17317136.001]
  • [Cites] Cornea. 2001 Jan;20(1):100-3 [11188990.001]
  • [Cites] Kidney Int. 2002 May;61(5):1714-28 [11967021.001]
  • [Cites] Nat Rev Mol Cell Biol. 2002 Mar;3(3):155-66 [11994736.001]
  • [Cites] Mol Pharmacol. 2002 Jul;62(1):58-64 [12065755.001]
  • [Cites] J Clin Invest. 2003 Nov;112(10):1486-94 [14617750.001]
  • [Cites] J Clin Invest. 2003 Dec;112(12):1776-84 [14679171.001]
  • [Cites] Am J Pathol. 2004 Feb;164(2):651-63 [14742269.001]
  • [Cites] Trends Cell Biol. 2004 Mar;14(3):107-11 [15055198.001]
  • [Cites] J Biol Chem. 2004 Jul 30;279(31):32325-32 [15173165.001]
  • [Cites] Lab Invest. 2004 Oct;84(10):1259-70 [15258599.001]
  • [Cites] Lab Invest. 2004 Oct;84(10):1245-58 [15273699.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1993 Nov;34(12):3320-8 [8225867.001]
  • [Cites] Cornea. 1993 Sep;12(5):383-90 [8306658.001]
  • [Cites] J Biol Chem. 2005 Jan 14;280(2):1024-36 [15520018.001]
  • [Cites] Am J Pathol. 2005 May;166(5):1393-403 [15855640.001]
  • [Cites] Am J Pathol. 2005 May;166(5):1405-18 [15855641.001]
  • [Cites] J Cell Physiol. 2005 Jul;204(1):260-72 [15690394.001]
  • [Cites] J Biol Chem. 2005 Jun 10;280(23):21858-66 [15811853.001]
  • [Cites] Lab Invest. 2005 Jul;85(7):838-50 [15924151.001]
  • [Cites] Lab Invest. 2006 Feb;86(2):106-15 [16341020.001]
  • [Cites] Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):19-27 [16290023.001]
  • [Cites] FEBS Lett. 2006 May 22;580(12):2811-20 [16678165.001]
  • [Cites] Arch Ophthalmol. 2007 May;125(5):647-54 [17502504.001]
  • [Cites] Cancer Res. 2007 Jun 1;67(11):5090-6 [17545585.001]
  • [Cites] J Biol Chem. 2007 Jul 27;282(30):22089-101 [17513865.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2008 Jan;49(1):93-104 [18172080.001]
  • [Cites] Prog Retin Eye Res. 2008 Mar;27(2):177-96 [18243038.001]
  • [Cites] Exp Eye Res. 2006 Dec;83(6):1309-16 [16769055.001]
  • (PMID = 19081766.001).
  • [ISSN] 1090-0535
  • [Journal-full-title] Molecular vision
  • [ISO-abbreviation] Mol. Vis.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies; 0 / Cytokines; 0 / Smad Proteins; 0 / Transforming Growth Factor beta1; 0 / Transforming Growth Factor beta2; EC 2.7.7.- / Cre recombinase; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC2600488
  •  go-up   go-down


54. Girardeau S, Mine S, Pageon H, Asselineau D: The Caucasian and African skin types differ morphologically and functionally in their dermal component. Exp Dermatol; 2009 Aug;18(8):704-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the literature, most reported differences between African and Caucasian skin properties concern pigmentation and barrier function of the stratum corneum and related photoprotective properties.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19469898.001).
  • [ISSN] 1600-0625
  • [Journal-full-title] Experimental dermatology
  • [ISO-abbreviation] Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Tissue Inhibitor of Metalloproteinase-1; 126469-10-1 / Fibroblast Growth Factor 7; 9007-34-5 / Collagen; EC 3.4.24.7 / Matrix Metalloproteinase 1
  •  go-up   go-down


55. Akita S, Akino K, Imaizumi T, Hirano A: Basic fibroblast growth factor accelerates and improves second-degree burn wound healing. Wound Repair Regen; 2008 Sep-Oct;16(5):635-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients receiving topical basic fibroblast growth factor (bFGF) or no bFGF were compared for clinical scar extent, passive scar hardness and elasticity using a Cutometer, direct scar hardness using a durometer, and moisture analysis of the stratum corneum at 1 year after complete wound healing.
  • Transepidermal water loss, water content, and corneal thickness were significantly less in bFGF-treated than in non-bFGF-treated scars (p<0.01).

  • MedlinePlus Health Information. consumer health - Burns.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19128258.001).
  • [ISSN] 1524-475X
  • [Journal-full-title] Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
  • [ISO-abbreviation] Wound Repair Regen
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 103107-01-3 / Fibroblast Growth Factor 2
  •  go-up   go-down


56. Proksch E, Brandner JM, Jensen JM: The skin: an indispensable barrier. Exp Dermatol; 2008 Dec;17(12):1063-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The physical barrier is mainly localized in the stratum corneum (SC) and consists of protein-enriched cells (corneocytes with cornified envelope and cytoskeletal elements, as well as corneodesmosomes) and lipid-enriched intercellular domains.


57. Nugroho AK, Romeijn SG, Zwier R, de Vries JB, Dijkstra D, Wikström H, Della-Pasqua O, Danhof M, Bouwstra JA: Pharmacokinetics and pharmacodynamics analysis of transdermal iontophoresis of 5-OH-DPAT in rats: in vitro-in vivo correlation. J Pharm Sci; 2006 Jul;95(7):1570-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pharmacokinetics and dopaminergic effect of dopamine agonist 5-OH-DPAT in vivo were determined following transdermal iontophoresis in rats based on drug concentration in plasma (C(p)) and dopamine levels in striatum (C(DA)).
  • Correlation of the in vitro transport with the pharmacokinetic-pharmacodynamic (PK-PD) profiles was characterized in the transport in dermatomed rat skin (DRS) and rat stratum corneum (RSC).
  • The integrated in vivo PK-PD and in vitro transport models successfully described time course of C(p), C(DA), and in vitro flux in DRS and RSC.
  • Based on nonlinear mixed-effect modeling, profiles of C(p) and C(DA) were successfully predicted using in vitro values of J(ss) in DRS with K(R) and t(L) in RSC.

  • Hazardous Substances Data Bank. DOPAMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16732562.001).
  • [ISSN] 0022-3549
  • [Journal-full-title] Journal of pharmaceutical sciences
  • [ISO-abbreviation] J Pharm Sci
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dopamine Agonists; 68593-96-4 / 5-hydroxy-2-N,N-dipropylaminotetralin; 78950-78-4 / 8-Hydroxy-2-(di-n-propylamino)tetralin; VTD58H1Z2X / Dopamine
  •  go-up   go-down


58. Mohan RR, Sharma A, Cebulko TC, Tandon A: Vector delivery technique affects gene transfer in the cornea in vivo. Mol Vis; 2010 Nov 27;16:2494-501
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vector delivery technique affects gene transfer in the cornea in vivo.
  • PURPOSE: This study tested whether controlled drying of the cornea increases vector absorption in mouse and rabbit corneas in vivo and human cornea ex vivo, and studied the effects of corneal drying on gene transfer, structure and inflammatory reaction in the mouse cornea in vivo.
  • A hair dryer was used for drying the corneas after removing corneal epithelium by gentle scraping.
  • Thereafter, balanced salt solution (BSS) was topically applied immediately on the cornea for 2 min using a custom-cloning cylinder.
  • The adeno-associated virus 8 (AAV8) vector (1.1×10(8) genomic copies/µl) expressing marker gene was used to study the effect of corneal drying on gene transfer.
  • RESULTS: Mice, rabbit or human corneas subjected to no or 10 s drying showed 6%-8% BSS absorption whereas 20, 30, or 50 s corneal drying showed significantly high 14%-19% (p<0.001), 21%-22% (p<0.001), and 25%-27% (p<0.001) BSS absorption, respectively.
  • The AAV8 application on mouse cornea after 50 s drying showed significantly higher transgene delivery (p<0.05) in vivo with mild-to-moderate changes in corneal morphology.
  • The 30 s of drying also showed significantly (p<0.05) high transgene delivery in mouse stroma in vivo without jeopardizing corneal morphology whereas 10 or 20 s drying showed moderate degree of gene transfer with no altered corneal morphology.
  • CONCLUSIONS: Controlled corneal drying with hair dryer increases vector absorption significantly.
  • The dispensing of efficacious AAV serotype into cornea with optimized minimally invasive topical application technique could provide high and targeted expression of therapeutic genes in the stroma in vivo without causing significant side effects.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Control Release. 2007 Dec 20;124(3):107-33 [17707107.001]
  • [Cites] Prog Retin Eye Res. 2005 Sep;24(5):537-59 [15955719.001]
  • [Cites] J Gene Med. 2008 Apr;10(4):375-82 [18278824.001]
  • [Cites] N Engl J Med. 2008 May 22;358(21):2231-9 [18441371.001]
  • [Cites] Int Ophthalmol. 2008 Jun;28(3):155-63 [17505780.001]
  • [Cites] Mol Vis. 2008;14:2087-96 [19023450.001]
  • [Cites] Curr Gene Ther. 2009 Feb;9(1):33-44 [19275570.001]
  • [Cites] Lancet. 2009 Nov 7;374(9701):1597-605 [19854499.001]
  • [Cites] Brain Res Bull. 2010 Feb 15;81(2-3):256-61 [19560524.001]
  • [Cites] Brain Res Bull. 2010 Feb 15;81(2-3):273-8 [19616080.001]
  • [Cites] Mol Vis. 2010;16:310-9 [20208988.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2010 Apr;51(4):1970-80 [19933191.001]
  • [Cites] Pharm Res. 2010 Jul;27(7):1398-407 [20387098.001]
  • [Cites] Exp Eye Res. 2010 Sep;91(3):440-8 [20599959.001]
  • [Cites] Vet Ophthalmol. 2010 Sep;13(5):301-6 [20840107.001]
  • [Cites] Int J Pharm. 2002 Jan 31;232(1-2):139-47 [11790497.001]
  • [Cites] Exp Eye Res. 2003 Mar;76(3):373-83 [12573666.001]
  • [Cites] Exp Eye Res. 2003 Jan;76(1):71-87 [12589777.001]
  • [Cites] Adv Exp Med Biol. 2002;506(Pt B):821-6 [12613998.001]
  • [Cites] Adv Exp Med Biol. 2002;506(Pt B):1315-21 [12614073.001]
  • [Cites] Trans Am Ophthalmol Soc. 1970;68:425-61 [5524214.001]
  • [Cites] Prog Retin Eye Res. 1999 May;18(3):311-56 [10192516.001]
  • [Cites] Vision Res. 2008 Feb;48(3):353-9 [17923143.001]
  • (PMID = 21139995.001).
  • [ISSN] 1090-0535
  • [Journal-full-title] Molecular vision
  • [ISO-abbreviation] Mol. Vis.
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / R01EY17294; United States / NEI NIH HHS / EY / R01 EY017294; United States / NEI NIH HHS / EY / EY017294-03S2; United States / NEI NIH HHS / EY / EY017294-03; United States / NEI NIH HHS / EY / R01 EY017294-03S2; United States / NEI NIH HHS / EY / R01 EY017294-03; United States / BLRD VA / BX / I01 BX000357
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD11b; 0 / Solutions; EC 3.1.3.1 / Alkaline Phosphatase
  • [Other-IDs] NLM/ PMC2997332
  •  go-up   go-down


59. Michaeli A, Rootman DS, Slomovic AR: [Corneal changes after phacoemulsification with a corneal versus a scleral tunnel incision]. Harefuah; 2006 Mar;145(3):191-3, 246
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Corneal changes after phacoemulsification with a corneal versus a scleral tunnel incision].
  • AIM: To compare central corneal thickness and endothelial cell loss after phacoemulsification with clear cornea and scleral tunnel incisions.
  • All patients had central corneal thickness measured preoperatively and on post-op days 1, 7, 30 and 90.
  • For the scleral tunnel group it was 1.8% +/- 21.5%, and for the clear cornea group 0.13% +/- 18.3% (p>0.05).
  • Corneal thickness increased significantly in all measurements post-op, and returned to baseline by 3 months.
  • CONCLUSIONS: Clear cornea and scleral tunnel incisions seem to result in no significant difference in endothelial cell loss and or central corneal thickness at 3 months post-op.
  • [MeSH-major] Cornea / physiology. Cornea / surgery. Phacoemulsification. Sclera / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16599314.001).
  • [ISSN] 0017-7768
  • [Journal-full-title] Harefuah
  • [ISO-abbreviation] Harefuah
  • [Language] heb
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Israel
  •  go-up   go-down


60. el-Mansy A: Revision of Myxobolus heterosporus Baker, 1963 (syn. Myxosoma Heterospora) (Myxozoa: Myxosporea) in African records. Dis Aquat Organ; 2005 Feb 28;63(2-3):205-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The present study revises the taxonomy, using specimens isolated from plasmodia situated in the infected cornea of Oreochromis aureus, O. niloticus or Tilapia zillii inhabiting the River Nile, Egypt.
  • [MeSH-minor] Animals. Body Weights and Measures. Cichlids. Cornea / parasitology. Egypt / epidemiology. Microscopy, Electron. Prevalence. Rivers. Species Specificity

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15819436.001).
  • [ISSN] 0177-5103
  • [Journal-full-title] Diseases of aquatic organisms
  • [ISO-abbreviation] Dis. Aquat. Org.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


61. Rabinowitz YS: Ectasia after laser in situ keratomileusis. Curr Opin Ophthalmol; 2006 Oct;17(5):421-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Several articles point out the limitations of the Orbscan (Bausch & Lomb, Rochester, New York, USA), in particular its accuracy and reproducibility with regard to data generated from the posterior surface of the cornea.
  • A biomechanical model of the cornea is proposed which suggests that each cornea's response to laser in situ keratomileusis is unique.
  • Several case reports are also reviewed which provide insight into pathogenesis and potential new treatment options; these include reports on histopathology, topographic pseudokeratectasia, ectasia from transient raised intraocular pressure, poor response to laser in situ keratomileusis after incisional surgery, intracorneal rings, collagen cross-linking and conductive keratoplasty to stabilize and sphericize the cornea with ectasia.
  • Insights into the biomechanics and genetics of the cornea may allow us to further reduce its occurrence.
  • [MeSH-major] Cornea / pathology. Corneal Diseases / etiology. Keratomileusis, Laser In Situ / adverse effects

  • MedlinePlus Health Information. consumer health - Corneal Disorders.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16932057.001).
  • [ISSN] 1040-8738
  • [Journal-full-title] Current opinion in ophthalmology
  • [ISO-abbreviation] Curr Opin Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 9007-34-5 / Collagen
  • [Number-of-references] 28
  •  go-up   go-down


62. Yamaguchi K, Mitsui T, Yamamoto T, Shiokawa R, Nomiyama Y, Ohishi N, Aso Y, Sugibayashi K: Analysis of in vitro skin permeation of 22-oxacalcitriol having a complicated metabolic pathway. Pharm Res; 2006 Apr;23(4):680-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The following parameters were obtained: metabolic rate of 1.37 x 10(-1) h(-1), and diffusion constants of OCT in stratum corneum (SC) (D(SC)) and viable epidermis and dermis (VED) (D(VED)) of 1.50 x 10(-7) and 2.96 x 10(-4) cm2/h, respectively.

  • Hazardous Substances Data Bank. 1,25-DIHYDROXYCHOLECALCIFEROL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pharm Sci. 1979 Nov;68(11):1341-6 [512880.001]
  • [Cites] J Pharm Sci. 1993 Aug;82(8):767-70 [8377110.001]
  • [Cites] Br J Dermatol. 1999 Aug;141(2):274-8 [10468799.001]
  • [Cites] J Theor Biol. 2000 Jun 7;204(3):393-407 [10816363.001]
  • [Cites] FEBS Lett. 1987 Dec 21;226(1):58-62 [2826255.001]
  • [Cites] Pharm Res. 1994 Mar;11(3):393-7 [8008705.001]
  • [Cites] J Pharmacobiodyn. 1981 Nov;4(11):879-85 [7328489.001]
  • [Cites] Toxicol Appl Pharmacol. 1985 Dec;81(3 Pt 1):502-16 [3936234.001]
  • [Cites] J Pharm Sci. 1995 Nov;84(11):1332-41 [8587052.001]
  • [Cites] J Pharmacobiodyn. 1988 Sep;11(9):636-44 [3216285.001]
  • [Cites] J Control Release. 1999 Nov 1;62(1-2):201-8 [10518652.001]
  • [Cites] Drug Metab Dispos. 2003 May;31(5):659-69 [12695356.001]
  • [Cites] Pharm Res. 1990 Mar;7(3):251-5 [2339098.001]
  • [Cites] Toxicol In Vitro. 1993 Mar;7(2):167-76 [20732186.001]
  • [Cites] Pharm Res. 1990 Sep;7(9):948-52 [2235895.001]
  • [Cites] Br J Dermatol. 1985 Dec;113(6):713-21 [3879455.001]
  • [Cites] Toxicol Sci. 2000 Nov;58(1):15-22 [11053536.001]
  • [Cites] Biochem Biophys Res Commun. 1987 Jun 15;145(2):749-53 [3593368.001]
  • [Cites] J Biol Chem. 1996 Apr 12;271(15):8700-8 [8621502.001]
  • [Cites] Skin Pharmacol Appl Skin Physiol. 2003 Nov-Dec;16(6):356-66 [14528059.001]
  • (PMID = 16550468.001).
  • [ISSN] 0724-8741
  • [Journal-full-title] Pharmaceutical research
  • [ISO-abbreviation] Pharm. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dermatologic Agents; FXC9231JVH / Calcitriol; N2UJM5NBF6 / maxacalcitol
  •  go-up   go-down


63. Mills PC, Magnusson BM, Cross SE: Effects of vehicle and region of application on absorption of hydrocortisone through canine skin. Am J Vet Res; 2005 Jan;66(1):43-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Saturated solutions of hydrocortisone that contained trace amounts of radiolabelled [14C]-hydrocortisone in each vehicle (ie, PBS solution [PBSS] alone, 50% ethanol [EtOH] in PBSS [wt/wt], and 50% propylene glycol in PBSS [wt/wt]) were applied to the outer (stratum corneum) surface of each skin sample, and aliquots of receptor fluid were collected for 24 hours and analyzed for hydrocortisone.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • Hazardous Substances Data Bank. Propylene glycol .
  • Hazardous Substances Data Bank. ETHANOL .
  • Hazardous Substances Data Bank. SODIUM CHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15691034.001).
  • [ISSN] 0002-9645
  • [Journal-full-title] American journal of veterinary research
  • [ISO-abbreviation] Am. J. Vet. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Pharmaceutical Vehicles; 3K9958V90M / Ethanol; 451W47IQ8X / Sodium Chloride; 6DC9Q167V3 / Propylene Glycol; WI4X0X7BPJ / Hydrocortisone
  •  go-up   go-down


64. Becht Ch: [Common immune mediated disorders of the conjunctiva in a general practice]. Praxis (Bern 1994); 2009 Apr 15;98(8):429-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Allergische Augenerkrankungen in der Praxis.
  • The symptoms and signs help to diagnose an immune-mediated disorder of the conjunctiva in the general practice.
  • The non ophthalmologist should be cautious in cases of severe atopia, involvement of the cornea and suspicion of corneal infection.
  • [MeSH-major] Conjunctivitis, Allergic / diagnosis
  • [MeSH-minor] Asthma / diagnosis. Asthma / etiology. Dermatitis, Atopic / diagnosis. Dermatitis, Atopic / etiology. Diagnosis, Differential. Humans. Patient Care Team. Referral and Consultation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19373760.001).
  • [ISSN] 1661-8157
  • [Journal-full-title] Praxis
  • [ISO-abbreviation] Praxis (Bern 1994)
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


65. Conrad AH, Albrecht M, Pettit-Scott M, Conrad GW: Embryonic corneal Schwann cells express some Schwann cell marker mRNAs, but no mature Schwann cell marker proteins. Invest Ophthalmol Vis Sci; 2009 Sep;50(9):4173-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Embryonic corneal Schwann cells express some Schwann cell marker mRNAs, but no mature Schwann cell marker proteins.
  • PURPOSE: Embryonic chick nerves encircle the cornea in pericorneal tissue until embryonic day (E)9, then penetrate the anterior corneal stroma, invade the epithelium, and branch over the corneal surface through E20.
  • Adult corneal nerves, cut during transplantation or LASIK, never fully regenerate.
  • Other corneas were paraffin embedded, sectioned, and processed by in situ hybridization for corneal-, nerve-related, and SC marker gene expression.
  • Antibodies against the MPZ, MAG, S100, and SCMP proteins immunostained along pericorneal nerves, but not along corneal nerves.
  • In the cornea, SLIT2 and SOX10 mRNAs were expressed in anterior stroma and epithelium, whereas PAX3, S100, MBP, and MPZL1 mRNAs were expressed only in corneal epithelium.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurosci Lett. 1987 Aug 18;79(1-2):40-6 [3313118.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1990 Oct;31(10):2008-21 [2210997.001]
  • [Cites] J Biol Chem. 1993 Mar 5;268(7):4930-8 [7680345.001]
  • [Cites] J Neuroimmunol. 1994 Aug;53(1):65-71 [7519633.001]
  • [Cites] J Cell Biol. 1994 Dec;127(6 Pt 2):2009-20 [7806578.001]
  • [Cites] J Biol Chem. 1995 Jun 16;270(24):14523-32 [7782315.001]
  • [Cites] Neuron. 1995 Sep;15(3):553-62 [7546735.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1996 Mar;37(4):476-88 [8595948.001]
  • [Cites] EMBO Rep. 2007 May;8(5):504-9 [17396138.001]
  • [Cites] J Invest Dermatol. 2007 Jun;127(6):1375-86 [17273165.001]
  • [Cites] Dev Biol. 2007 Jun 15;306(2):750-9 [17499699.001]
  • [Cites] Neuron. 1997 Sep;19(3):575-89 [9331350.001]
  • [Cites] Development. 1997 Nov;124(21):4287-95 [9334277.001]
  • [Cites] Dev Biol. 1997 Dec 15;192(2):258-73 [9441666.001]
  • [Cites] Annu Rev Neurosci. 1998;21:309-45 [9530499.001]
  • [Cites] J Neurosci Methods. 1998 Nov 1;85(1):63-71 [9874142.001]
  • [Cites] J Biol Chem. 1999 Jun 18;274(25):17885-92 [10364234.001]
  • [Cites] J Neurosci. 1999 Jun 15;19(12):4938-47 [10366627.001]
  • [Cites] Cell. 1999 Jun 25;97(7):927-41 [10399920.001]
  • [Cites] Mol Cell Neurosci. 2005 Jan;28(1):18-29 [15607938.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 May;46(5):1604-14 [15851558.001]
  • [Cites] Nature. 2005 Jun 16;435(7044):948-53 [15843801.001]
  • [Cites] Neuron. 2005 Sep 1;47(5):681-94 [16129398.001]
  • [Cites] Neuroscience. 2005;135(1):97-109 [16054765.001]
  • [Cites] Am J Ophthalmol. 2005 Dec;140(6):1059-1064 [16376651.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2006 Jan;47(1):120-32 [16384953.001]
  • [Cites] J Neurosci. 2006 Jan 11;26(2):508-17 [16407548.001]
  • [Cites] Exp Neurol. 2006 Apr;198(2):438-49 [16442526.001]
  • [Cites] J Neurosci. 2006 Aug 2;26(31):8082-91 [16885222.001]
  • [Cites] Science. 2006 Oct 27;314(5799):664-6 [16990514.001]
  • [Cites] BMC Neurosci. 2007;8:2 [17199889.001]
  • [Cites] Chem Immunol Allergy. 2007;92:58-70 [17264483.001]
  • [Cites] Glia. 2000 Jan 15;29(2):104-11 [10625327.001]
  • [Cites] Exp Eye Res. 2000 Mar;70(3):349-62 [10712821.001]
  • [Cites] Mol Cell Biol. 2000 May;20(9):3198-209 [10757804.001]
  • [Cites] J Neurosci. 2000 Jul 1;20(13):4962-74 [10864954.001]
  • [Cites] Brain Res Dev Brain Res. 2000 Jun 30;121(2):233-41 [10876038.001]
  • [Cites] J Immunol. 2000 Nov 15;165(10):5443-50 [11067896.001]
  • [Cites] J Histochem Cytochem. 2001 Jan;49(1):1-8 [11118473.001]
  • [Cites] Genes Dev. 2001 Jan 1;15(1):66-78 [11156606.001]
  • [Cites] Development. 2001 Apr;128(7):1059-68 [11245571.001]
  • [Cites] Mech Dev. 2001 Mar;101(1-2):47-59 [11231058.001]
  • [Cites] J Virol. 2001 Jun;75(11):5252-62 [11333907.001]
  • [Cites] Mol Cell Neurosci. 2001 Jun;17(6):1048-58 [11414793.001]
  • [Cites] Cells Tissues Organs. 2001;169(4):355-60 [11490114.001]
  • [Cites] Mol Vis. 2001 Dec 21;7:297-304 [11754335.001]
  • [Cites] Dev Biol. 2001 Nov 15;239(2):323-37 [11784038.001]
  • [Cites] Neuroscience. 2002;109(2):371-88 [11801372.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8856-61 [12084930.001]
  • [Cites] J Neurosci. 2007 Jun 20;27(25):6843-51 [17581972.001]
  • [Cites] Nat Neurosci. 2007 Jul;10(7):861-9 [17558405.001]
  • [Cites] Development. 2007 Sep;134(18):3271-81 [17699610.001]
  • [Cites] J Cell Biol. 2007 Aug 27;178(5):861-74 [17724124.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2008 Jan;49(1):139-53 [18172086.001]
  • [Cites] J Cell Biol. 2008 May 19;181(4):625-37 [18490512.001]
  • [Cites] Nat Cell Biol. 2008 Jun;10(6):698-706 [18469807.001]
  • [Cites] Neurosci Lett. 2008 Jul 4;439(1):42-6 [18502047.001]
  • [Cites] J Peripher Nerv Syst. 2008 Jun;13(2):122-35 [18601657.001]
  • [Cites] J Morphol. 1951 Jan;88(1):49-92 [24539719.001]
  • [Cites] FASEB J. 1996 Feb;10(2):293-301 [8641562.001]
  • [Cites] J Neurosci Res. 1996 Dec 1;46(5):630-40 [8951674.001]
  • [Cites] J Neurosci. 1997 Mar 1;17(5):1642-59 [9030624.001]
  • [Cites] Nature. 1997 Apr 24;386(6627):833-8 [9126742.001]
  • [Cites] J Neurosci Res. 2002 Oct 1;70(1):46-56 [12237863.001]
  • [Cites] Biochem J. 2003 Mar 1;370(Pt 2):537-49 [12410637.001]
  • [Cites] Exp Eye Res. 2003 May;76(5):521-42 [12697417.001]
  • [Cites] J Cutan Pathol. 2003 Jul;30(6):373-8 [12834486.001]
  • [Cites] Matrix Biol. 2003 Jun;22(4):323-37 [12935817.001]
  • [Cites] Dev Cell. 2003 Nov;5(5):695-707 [14602071.001]
  • [Cites] Science. 2004 Apr 30;304(5671):700-3 [15044753.001]
  • [Cites] Curr Opin Cell Biol. 2004 Oct;16(5):513-21 [15363801.001]
  • [Cites] Dev Biol. 1982 Jul;92(1):5-15 [6179807.001]
  • [Cites] Acta Ophthalmol (Copenh). 1985 Apr;63(2):207-14 [3890460.001]
  • [Cites] Ann N Y Acad Sci. 1986;486:132-46 [3551735.001]
  • [Cites] J Biol Chem. 1987 Aug 25;262(24):11634-40 [2957372.001]
  • (PMID = 19387082.001).
  • [ISSN] 1552-5783
  • [Journal-full-title] Investigative ophthalmology & visual science
  • [ISO-abbreviation] Invest. Ophthalmol. Vis. Sci.
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / R01 EY000952-36; United States / Howard Hughes Medical Institute / / HHMI 52003734; United States / NEI NIH HHS / EY / R01 EY000952; United States / NEI NIH HHS / EY / EY000952; United States / NEI NIH HHS / EY / EY000952-36
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Avian Proteins; 0 / Biomarkers; 0 / DNA Primers; 0 / Nerve Tissue Proteins; 0 / RNA Probes; 0 / RNA, Messenger
  • [Other-IDs] NLM/ NIHMS143615; NLM/ PMC2771572
  •  go-up   go-down


66. Saelens IE, Bleyen I, Hillenaar T, Thiadens AA, Beekhuis WH, Remeijer L, Van Rij G: Long-term follow-up of hydrogel intracorneal lenses in 2 aphakic eyes. J Cataract Refract Surg; 2010 Dec;36(12):2200-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The lenses were implanted at approximately 50% depth in the cornea to correct high hyperopic refractive errors of 10.5 diopters (D) and 14.0 D, respectively.
  • Long-term patient monitoring is essential since corneal opacities can develop after many years.
  • Removing the implant is not necessary as the lens can easily be rinsed by lifting the corneal cap.
  • [MeSH-major] Aphakia, Postcataract / surgery. Corneal Opacity / etiology. Corneal Stroma / surgery. Hydrogel. Hyperopia / surgery. Lenses / adverse effects

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.
  • (PMID = 21111324.001).
  • [ISSN] 1873-4502
  • [Journal-full-title] Journal of cataract and refractive surgery
  • [ISO-abbreviation] J Cataract Refract Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 25852-47-5 / Hydrogel
  •  go-up   go-down


67. Ergün SS, Kocabora MS, Su O, Demirkesen C: Surgical treatment of giant pyogenic granuloma of the upper eyelid. Ann Ophthalmol (Skokie); 2007;39(3):264-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pyogenic granuloma (PG), also known as lobular capillary hemangioma, is a benign acquired vascular lesion of the skin and mucous membranes.
  • Diagnosis is aided by history of surgery, trauma or inflammation and characteristic clinical appearance, whereas, definitive diagnosis is made by histopathologic findings.
  • From an ophthalmic perspective, a PG may be located on the eyelids, conjunctiva or rarely on the cornea.

  • Genetic Alliance. consumer health - Pyogenic Granuloma.
  • MedlinePlus Health Information. consumer health - Eyelid Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18025641.001).
  • [ISSN] 1558-9951
  • [Journal-full-title] Annals of ophthalmology (Skokie, Ill.)
  • [ISO-abbreviation] Ann Ophthalmol (Skokie)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Casiraghi A, Minghetti P, Cilurzo F, Selmin F, Gambaro V, Montanari L: The effects of excipients for topical preparations on the human skin permeability of terpinen-4-ol contained in Tea tree oil: infrared spectroscopic investigations. Pharm Dev Technol; 2010 Sep-Oct;15(5):545-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The effect of such excipients was determined by evaluating the absorption of T4OL using human epidermis and the perturbation of the organization of stratum corneum by ATR-FTIR.
  • Among the tested excipients OA enhanced the absorption of T4OL by perturbing the stratum corneum lipid barrier.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Tea tree oil .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19842911.001).
  • [ISSN] 1097-9867
  • [Journal-full-title] Pharmaceutical development and technology
  • [ISO-abbreviation] Pharm Dev Technol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Excipients; 0 / Terpenes; 562-74-3 / terpinenol-4; 68647-73-4 / Tea Tree Oil
  •  go-up   go-down


69. Alió JL, Shabayek MH, Montes-Mico R, Múlet ME, Ahmed AG, Merayo J: Intracorneal hydrogel lenses and corneal aberrations. J Refract Surg; 2005 May-Jun;21(3):247-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracorneal hydrogel lenses and corneal aberrations.
  • PURPOSE: To investigate the optical performance of the cornea based on corneal aberrometry following intracorneal hydrogel lens implantation.
  • METHODS: A retrospective, nonconsecutive, observational study of the anterior corneal surface aberration profile of four hyperopic eyes previously implanted with an intracorneal hydrogel lens were studied by videokeratographic elevation maps before and 6 months after surgery.
  • CONCLUSIONS: Intracorneal hydrogel lenses decreased the optical performance of the cornea by significantly increasing spherical, coma, and total higher order aberrations.
  • [MeSH-major] Corneal Stroma / physiopathology. Corneal Stroma / surgery. Hydrogel. Hyperopia / surgery. Lenses, Intraocular
  • [MeSH-minor] Adult. Corneal Topography. Humans. Middle Aged. Prosthesis Implantation. Refraction, Ocular / physiology. Retrospective Studies. Visual Acuity / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15977881.001).
  • [ISSN] 1081-597X
  • [Journal-full-title] Journal of refractive surgery (Thorofare, N.J. : 1995)
  • [ISO-abbreviation] J Refract Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 25852-47-5 / Hydrogel
  •  go-up   go-down


71. Chiou AG, Kaufman SC, Kaufman HE, Beuerman RW: Clinical corneal confocal microscopy. Surv Ophthalmol; 2006 Sep-Oct;51(5):482-500
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical corneal confocal microscopy.
  • Its unique physical properties enable microscopic examination of all layers of the cornea and have been used to investigate numerous corneal diseases: epithelial changes, numerous stromal degenerative or dystrophic diseases, endothelial pathologies, corneal deposits, infections, and traumatic lesions.
  • It offers a new approach to study the physiological reactions of the cornea to different stimuli and the pathophysiologic events leading to corneal dysfunction in certain diseases.
  • Confocal microscopy proves to be a powerful diagnostic tool and is especially of value in certain corneal diseases by allowing straightforward and non-invasive recognition of the pathologic conditions.
  • [MeSH-major] Cornea / pathology. Corneal Diseases / diagnosis. Microscopy, Confocal / methods
  • [MeSH-minor] Corneal Stroma / pathology. Endothelium, Corneal / pathology. Epithelium, Corneal / pathology. Humans

  • MedlinePlus Health Information. consumer health - Corneal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16950248.001).
  • [ISSN] 0039-6257
  • [Journal-full-title] Survey of ophthalmology
  • [ISO-abbreviation] Surv Ophthalmol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 229
  •  go-up   go-down


72. Bahar I, Kaiserman I, Livny E, Slomovic A, Slomovic A: Changes in corneal curvatures and anterior segment parameters after descemet stripping automated endothelial keratoplasty. Curr Eye Res; 2010 Nov;35(11):961-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Changes in corneal curvatures and anterior segment parameters after descemet stripping automated endothelial keratoplasty.
  • PURPOSE: To evaluate the influence of Descemet stripping automated endothelial keratoplasty (DSAEK) on corneal curvature and the anterior segment parameters obtained with the Pentacam rotating Scheimpflug camera.
  • We compared preoperative and 1- and 3-month postoperative measurements of anterior and posterior corneal curvature, anterior and posterior corneal astigmatism, anterior chamber depth (ACD), anterior chamber volume (ACV), anterior chamber angle (ACA) width, central corneal thickness (CCT), and the corneal volume (CV).
  • Anterior mean K reading of the cornea flattened from 43.3 ± 1.65 diopter before surgery to 42.7 ± 1.5 diopter at 3 months (p = 0.03).
  • Anterior corneal astigmatism did not change significantly.
  • Posterior mean K reading of the cornea steepened significantly from -5.6 ± 0.6 diopter preoperatively to -7.2 ± 0.4 diopter at 3 months (p = 0.007).
  • Posterior corneal astigmatism increased accordingly from 0.52 ± 0.17 diopter before surgery to 0.95 ± 0.57 diopter at 3 months (p = 0.07).
  • CONCLUSIONS: DSAEK significantly increased posterior corneal k-reading, posterior corneal astigmatism, and corneal volume, resulting in a mild hyperopic shift.
  • [MeSH-major] Anterior Eye Segment / pathology. Astigmatism / physiopathology. Cornea / pathology. Descemet Stripping Endothelial Keratoplasty. Hyperopia / physiopathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20958184.001).
  • [ISSN] 1460-2202
  • [Journal-full-title] Current eye research
  • [ISO-abbreviation] Curr. Eye Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


73. Rohini G, Murugeswari P, Prajna NV, Lalitha P, Muthukkaruppan V: Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis. Cornea; 2007 Feb;26(2):207-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To study the infiltrating cells and quantify the levels of matrix metalloproteinases (MMP-8, MMP-9) and tissue inhibitor of metalloproteinases (TIMP-1, TIMP-2) in the cornea, tear, and serum of patients with fungal keratitis.
  • Infected corneal tissue from 4 patients with fungal keratitis (group 1) scheduled to undergo therapeutic keratoplasty accounted for the histopathologic and cytospin smear analysis.
  • Corneal buttons obtained during keratoplasty, 15 to 20 microL of tears collected using the capillary flow method, and 3 mL of blood was obtained from patients with fungal keratitis and patients with keratoconus.
  • Corneal button sections from group 1 were stained with hematoxylin and eosin and Grocott methenamine silver nitrate for the histopathologic studies and Giemsa staining for the cytospin smear analysis.
  • Enzyme-linked immunosorbent assay was used for the quantification of total MMP-8, MMP-9, TIMP-1, and TIMP-2 in the corneal homogenates, tear, and serum samples of group 2.
  • RESULTS: Corneal sections from group 1 revealed dense fungal filaments and a large proportion (91.4% +/- 38%) of polymorphonuclear leukocytes (PMNs).
  • CONCLUSIONS: Infiltrating PMNs in the cornea of patients with fungal keratitis contributed to the increased activities of MMP-8 and MMP-9, thereby enhancing tissue destruction and derangement.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers / metabolism. Cornea / enzymology. Cornea / microbiology. Cornea / pathology. Enzyme-Linked Immunosorbent Assay. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neutrophils / pathology. Severity of Illness Index. Tears / enzymology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17251814.001).
  • [ISSN] 0277-3740
  • [Journal-full-title] Cornea
  • [ISO-abbreviation] Cornea
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Tissue Inhibitor of Metalloproteinase-1; 127497-59-0 / Tissue Inhibitor of Metalloproteinase-2; EC 3.4.24.34 / Matrix Metalloproteinase 8; EC 3.4.24.35 / Matrix Metalloproteinase 9
  •  go-up   go-down


74. Diridollou S, de Rigal J, Querleux B, Leroy F, Holloway Barbosa V: Comparative study of the hydration of the stratum corneum between four ethnic groups: influence of age. Int J Dermatol; 2007 Oct;46 Suppl 1:11-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative study of the hydration of the stratum corneum between four ethnic groups: influence of age.
  • METHODS: The skin water content was evaluated taking advantage of the new skin capacitance imaging technique which allows to study stratum corneum hydration without suffering of the influence of the skin micro-relief and hair on the measurement.

  • MedlinePlus Health Information. consumer health - Seniors' Health.
  • MedlinePlus Health Information. consumer health - Skin Aging.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17919198.001).
  • [ISSN] 0011-9059
  • [Journal-full-title] International journal of dermatology
  • [ISO-abbreviation] Int. J. Dermatol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


75. Giuliano EA: Feline ocular emergencies. Clin Tech Small Anim Pract; 2005 May;20(2):135-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Common feline emergencies include proptosis, lid lacerations, corneal ulcers, and foreign bodies.
  • Complete ophthalmic examination including procurement of the minimal ophthalmic database (Schirmer tear test, fluorescein stain, and intraocular pressure measurement) should be obtained whenever possible to ensure that the complete and correct diagnosis is made.
  • This article reviews some of the more common feline ocular emergencies, including conditions affecting the orbit and globe, adnexa, conjunctiva, and cornea.
  • [MeSH-major] Cat Diseases / diagnosis. Cat Diseases / therapy. Emergency Treatment / veterinary. Eye Diseases / veterinary. Eye Injuries / veterinary

  • MedlinePlus Health Information. consumer health - Eye Diseases.
  • MedlinePlus Health Information. consumer health - Eye Injuries.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15948429.001).
  • [ISSN] 1096-2867
  • [Journal-full-title] Clinical techniques in small animal practice
  • [ISO-abbreviation] Clin Tech Small Anim Pract
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 20
  •  go-up   go-down


76. Kong F, Li W, Li X, Zheng Q, Dai X, Zhou X, Boye SL, Hauswirth WW, Qu J, Pang JJ: Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse. Exp Eye Res; 2010 May;90(5):546-54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To clarify whether transduction efficiency and cell type specificity of self-complementary (sc) AAV5 vectors are similar to those of standard, single-stranded AAV5 vectors in normal retina, one micro liter of scAAV5-smCBA-GFP vector (1 x 10(12) genome-containing particles/ml) and AAV5-smCBA-GFP vector (1 x 10(12) genome-containing particles/ml) were subretinally or intravitreally (in both cases through the cornea) injected into the right and left eyes of adult C57BL/6J mice, respectively.
  • GFP expression following trans-cornea subretinal injection of scAAV5-smCBA-GFP vector was first detected in RPE wholemounts around PID 1 and in neuroretinal wholemounts between PID 2 and 5; GFP expression peaked and stabilized between PID 10-14 in RPE wholemounts and between P14 and P21 in neuroretinal wholemounts with strong, homogeneous green fluorescence covering the entire wholemounts.
  • No GFP fluorescence was detected in any retinal cells (RPE wholemounts, neuroretinal wholemounts and retinal sections) after trans-cornea intravitreal delivery of either scAAV5-GFP or AAV5-GFP.
  • Neither scAAV5 nor AAV5 can transduce retinal cells following trans-cornea intravitreal injection.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Elsevier Ltd. All rights reserved.
  • [Cites] Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3428-32 [10688913.001]
  • [Cites] Hum Gene Ther. 2009 Sep;20(9):999-1004 [19583479.001]
  • [Cites] J Virol. 2002 Jan;76(2):791-801 [11752169.001]
  • [Cites] J Virol. 2002 Aug;76(15):7651-60 [12097579.001]
  • [Cites] Methods. 2002 Oct;28(2):158-67 [12413414.001]
  • [Cites] Gene Ther. 2003 Aug;10(16):1336-44 [12883530.001]
  • [Cites] Gene Ther. 2003 Dec;10(26):2105-11 [14625564.001]
  • [Cites] Gene Ther. 2003 Dec;10(26):2112-8 [14625565.001]
  • [Cites] Mol Ther. 2003 Dec;8(6):911-7 [14664793.001]
  • [Cites] Am J Anat. 1972 Feb;133(2):179-212 [5009246.001]
  • [Cites] J Virol. 1996 Jan;70(1):520-32 [8523565.001]
  • [Cites] J Virol. 1996 May;70(5):3227-34 [8627803.001]
  • [Cites] J Virol. 1996 Jul;70(7):4646-54 [8676491.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6916-21 [9192666.001]
  • [Cites] Vision Res. 1999 Jul;39(15):2545-53 [10396623.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9920-5 [10449795.001]
  • [Cites] Mol Vis. 2005 Feb 28;11:152-62 [15765048.001]
  • [Cites] Mol Ther. 2005 Apr;11(4):523-30 [15771955.001]
  • [Cites] Hum Gene Ther. 2005 Jun;16(6):649-63 [15960597.001]
  • [Cites] Mol Ther. 2006 Mar;13(3):565-72 [16223604.001]
  • [Cites] Blood. 2006 Apr 1;107(7):2653-61 [16322469.001]
  • [Cites] J Gene Med. 2006 May;8(5):589-602 [16506246.001]
  • [Cites] Mol Vis. 2006;12:756-67 [16862069.001]
  • [Cites] Gene Ther. 2006 Aug;13(16):1191-7 [16838031.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3745-53 [16936082.001]
  • [Cites] J Comp Neurol. 2007 Jan 10;500(2):222-38 [17111372.001]
  • [Cites] Vision Res. 2007 Mar;47(5):624-33 [17267005.001]
  • [Cites] Hum Gene Ther. 2007 Feb;18(2):171-82 [17328683.001]
  • [Cites] Nat Med. 2007 Jun;13(6):685-7 [17515894.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3324-8 [17591905.001]
  • [Cites] Vision Res. 2008 Feb;48(3):377-85 [17950399.001]
  • [Cites] Gene Ther. 2008 Mar;15(6):463-7 [18004402.001]
  • [Cites] N Engl J Med. 2008 May 22;358(21):2240-8 [18441370.001]
  • [Cites] N Engl J Med. 2008 May 22;358(21):2231-9 [18441371.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15112-7 [18809924.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4278-83 [18586879.001]
  • [Cites] Mol Vis. 2008;14:1760-9 [18836574.001]
  • [Cites] Mol Vis. 2009;15:267-75 [19190735.001]
  • [Cites] Mol Ther. 2009 Mar;17(3):463-71 [19066593.001]
  • [Cites] N Engl J Med. 2009 Aug 13;361(7):725-7 [19675341.001]
  • [Cites] Hum Mol Genet. 2001 Dec 15;10(26):3075-81 [11751689.001]
  • (PMID = 20138034.001).
  • [ISSN] 1096-0007
  • [Journal-full-title] Experimental eye research
  • [ISO-abbreviation] Exp. Eye Res.
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / EY018331-01; United States / NICHD NIH HHS / HD / N01AA21004; United States / NEI NIH HHS / EY / R21 EY018331-01; United States / NEI NIH HHS / EY / P30 EY021721; United States / NEI NIH HHS / EY / EY018331; United States / NEI NIH HHS / EY / R21 EY018331
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ NIHMS177507; NLM/ PMC2854182
  •  go-up   go-down


77. Takeda K, Takahashi NH, Shibahara S: Neuroendocrine functions of melanocytes: beyond the skin-deep melanin maker. Tohoku J Exp Med; 2007 Mar;211(3):201-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The skin is armored with "dead cells", the stratum corneum, and is continuously exposed to external stressful environments, such as atmospheric oxygen, solar radiations, and thermal and chemical insults.
  • Moreover, heterozygous mutations in the gene coding for microphthalmia-associated transcription factor, a key regulator for melanocyte development, are associated with Waardenburg syndrome type 2, an auditory-pigmentary disorder.


78. Fujita E, Teramura Y, Mitsugi K, Ninomiya S, Iwatsubo T, Kawamura A, Kamimura H: Absorption, distribution, and excretion of 14C-labeled tacrolimus (FK506) after a single or repeated ocular instillation in rabbits. J Ocul Pharmacol Ther; 2008 Jun;24(3):333-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In eyeball microautoradiograms, 15 min after dosing, the level of radioactivity in the cornea was the highest, followed by conjunctiva.
  • After 1 h, little specific distribution was detected in the corneal epithelium, stroma, or Descemet's membrane.
  • At 24 h, the level of radioactivity in the cornea decreased.
  • CONCLUSIONS: After the ocular instillation, FK506 is first absorbed in the cornea, conjunctiva, and nasolacrimal duct, and then the rest is distributed to digestive tract through the nasal meatus and esophagus, after which it is excreted mainly into the feces.

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18476802.001).
  • [ISSN] 1080-7683
  • [Journal-full-title] Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • [ISO-abbreviation] J Ocul Pharmacol Ther
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Immunosuppressive Agents; 0 / Ophthalmic Solutions; 0 / Suspensions; WM0HAQ4WNM / Tacrolimus
  •  go-up   go-down


79. Bourghardt Peebo B, Gan L, Sun XF, Knutsen A, Rearden A, Fagerholm P: Expression of the focal adhesion protein PINCH in normal and alkali-injured corneas and the role of PMNs. Acta Ophthalmol Scand; 2007 Jun;85(4):395-400
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To evaluate the role of particularly interesting new cysteine-histidine-rich protein (PINCH) in corneal wound healing and early neovascularization and to assess the influence of granulocytes.
  • METHODS: A standardized corneal alkali wound was inflicted under general anaesthesia to the right eye of 14 New Zealand White rabbits.
  • RESULTS: In the normal cornea and limbus, PINCH was weakly expressed in the corneal epithelium and in a wedge of the conjunctival stroma.
  • CONCLUSIONS: PINCH is only slightly expressed in the normal cornea.
  • A corneal wound induces PINCH expression in the repopulating cells, in the vascular endothelial cells of the limbus, in the limbal epithelium and in the granulocytes.
  • [MeSH-major] Burns, Chemical / metabolism. Cornea / metabolism. DNA-Binding Proteins / metabolism. Eye Burns / chemically induced. Focal Adhesions / metabolism. Neutrophils / physiology
  • [MeSH-minor] Animals. Anticoagulants / pharmacology. Azepines. Corneal Injuries. Disease Models, Animal. Endothelium, Vascular / metabolism. Immunoenzyme Techniques. Lidocaine / analogs & derivatives. Polysaccharides / pharmacology. Rabbits. Sodium Hydroxide / toxicity. Wound Healing. Zinc Fingers

  • Hazardous Substances Data Bank. SODIUM HYDROXIDE .
  • Hazardous Substances Data Bank. LIDOCAINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17559464.001).
  • [ISSN] 1395-3907
  • [Journal-full-title] Acta ophthalmologica Scandinavica
  • [ISO-abbreviation] Acta Ophthalmol Scand
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Anticoagulants; 0 / Azepines; 0 / DNA-Binding Proteins; 0 / Polysaccharides; 55X04QC32I / Sodium Hydroxide; 66803GMO3G / pincainide; 9072-19-9 / fucoidan; 98PI200987 / Lidocaine
  •  go-up   go-down


80. Gatinel D, Chaabouni S, Adam PA, Munck J, Puech M, Hoang-Xuan T: Corneal hysteresis, resistance factor, topography, and pachymetry after corneal lamellar flap. J Refract Surg; 2007 Jan;23(1):76-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Corneal hysteresis, resistance factor, topography, and pachymetry after corneal lamellar flap.
  • PURPOSE: To measure prospectively the early changes in corneal hysteresis, topography, and pachymetry after the creation of a stromal flap cut without laser photoablation.
  • A 159-microm-thick 8x8.5-mm superior hinged flap was created with a mechanical microkeratome in the left cornea.
  • Changes in the corneal hysteresis, corneal resistance factor, Goldmann correlated intraocular pressure (lOP), corneal compensated IOP, anterior and posterior topography, and optical and ultrasound pachymetry were monitored prospectively before and at 1 hour, 1 day, 5 days, and 25 days after flap creation.
  • RESULTS: In the left eye, corneal hysteresis and corneal resistance factor decreased immediately after the flap cut and remained lower than preoperatively at 1 hour, 1 day, 5 days, and 25 days.
  • Corneal compensated IOP varied significantly less than Goldmann correlated IOP in both eyes.
  • Increased central corneal thickness occurred immediately after the flap cut and decreased over time without returning to its preoperative value.
  • CONCLUSIONS: The creation of a stromal flap can modify the biomechanical properties of the cornea, including a reduction in corneal hysteresis.
  • [MeSH-major] Anisometropia / surgery. Astigmatism / surgery. Cornea. Corneal Topography. Corneal Transplantation / methods. Intraocular Pressure / physiology. Myopia / surgery. Surgical Flaps

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17269247.001).
  • [ISSN] 1081-597X
  • [Journal-full-title] Journal of refractive surgery (Thorofare, N.J. : 1995)
  • [ISO-abbreviation] J Refract Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Alvord LA, Hall WJ, Keyes LD, Morgan CF, Winterton LC: Corneal oxygen distribution with contact lens wear. Cornea; 2007 Jul;26(6):654-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Corneal oxygen distribution with contact lens wear.
  • PURPOSE: Since 1991, multilayer mathematical in vivo oxygenation models have been created to predict normal corneal oxygenation with contact lens wear.
  • From these models, there have been assertions that most hydrogel contact lenses allow 97%-98% of normal corneal oxygenation compared to no contact lens wear.
  • This work seeks to validate or refute those preexisting models and estimate the impact of contact lens wear on the oxygen distribution profile across the cornea.
  • To this end, to estimate the impact of contact lens wear on the 3-dimensional (3-D) oxygen distribution profile within the cornea as a function of the oxygen permeability of the contact lens, a two-dimensional axisymetric finite element analysis (FEA) model was constructed for contact lenses, on the cornea, both having varying thickness profiles.
  • The model included the varying thickness profiles of the contact lens and cornea.
  • RESULTS: Profiles of the oxygen partial pressure, flux, and consumption were generated from the central cornea to the limbal junction.
  • CONCLUSION: This FEA model reproduced Brennan 8-layer model (BEL model) results at the central cornea.
  • However, BEL model parameters yielded regions of oxygen deficiency in the corneal periphery, even in the open eye with no contact lens.
  • If the BEL model cannot account for oxygenation across the whole cornea, it may be incorrect or incomplete.
  • [MeSH-major] Contact Lenses, Hydrophilic. Cornea / metabolism. Myopia / metabolism. Myopia / therapy. Oxygen / metabolism. Oxygen Consumption / physiology

  • Hazardous Substances Data Bank. OXYGEN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Cornea. 2008 Feb;27(2):258-9; author reply 259-60 [18216593.001]
  • (PMID = 17592312.001).
  • [ISSN] 0277-3740
  • [Journal-full-title] Cornea
  • [ISO-abbreviation] Cornea
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] S88TT14065 / Oxygen
  •  go-up   go-down


82. Gealy EC, Kerr BC, Young RD, Tudor D, Hayes AJ, Hughes CE, Caterson B, Quantock AJ, Ralphs JR: Differential expression of the keratan sulphate proteoglycan, keratocan, during chick corneal embryogenesis. Histochem Cell Biol; 2007 Dec;128(6):551-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential expression of the keratan sulphate proteoglycan, keratocan, during chick corneal embryogenesis.
  • Keratan sulphate (KS) proteoglycans (PGs) are key molecules in the connective tissue matrix of the cornea of the eye, where they are believed to have functional roles in tissue organisation and transparency.
  • Keratocan, is one of the three KS PGs expressed in cornea, and is the only one that is primarily cornea-specific.
  • Work with the developing chick has shown that mRNA for keratocan is present in early corneal embryogenesis, but there is no evidence of protein synthesis and matrix deposition.
  • Here, we investigate the tissue distribution of keratocan in the developing chick cornea as it becomes compacted and transparent in the later stages of development.
  • By E14 when the cornea begins to become transparent, keratocan was located in elongate arrays, presumably associated along collagen fibrils in the stroma.
  • Thus, in embryonic chick cornea, keratocan, in common with sulphated KS chains in the E12-E14 developmental period, exhibits a preferential distribution in the anterior stroma.
  • It undergoes a striking reorganisation of structure and distribution consistent with a role in relation to stromal compaction and corneal transparency.
  • [MeSH-minor] Animals. Cornea / embryology. Embryonic Development. Immunohistochemistry. Keratan Sulfate / genetics. Keratan Sulfate / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biochem. 1999 Nov;126(5):804-14 [10544271.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4046-9 [16249479.001]
  • [Cites] Biochem J. 1995 Feb 1;305 ( Pt 3):799-804 [7531436.001]
  • [Cites] J Cell Biol. 1998 Jun 1;141(5):1277-86 [9606218.001]
  • [Cites] Nat Genet. 2000 May;25(1):91-5 [10802664.001]
  • [Cites] Coll Relat Res. 1986 Jun;6(2):203-18 [3731748.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 May;46(5):1604-14 [15851558.001]
  • [Cites] J Biol Chem. 1998 Apr 17;273(16):9615-21 [9545293.001]
  • [Cites] Exp Eye Res. 1961 Dec;1:116-21 [13861727.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1994 Mar;35(3):870-7 [8125750.001]
  • [Cites] Dev Biol. 1986 Aug;116(2):267-77 [2942429.001]
  • [Cites] Exp Eye Res. 2006 Feb;82(2):183-4 [16360151.001]
  • [Cites] Exp Eye Res. 2004 May;78(5):909-15 [15051472.001]
  • [Cites] J Biol Chem. 1983 Jul 25;258(14 ):8848-54 [6223038.001]
  • [Cites] Biochim Biophys Acta. 1975 Jan 13;381(1):203-14 [122899.001]
  • [Cites] J Biol Chem. 2003 Jun 13;278(24):21672-7 [12665512.001]
  • [Cites] Matrix Biol. 2003 Jun;22(4):323-37 [12935817.001]
  • [Cites] Exp Eye Res. 1975 Jul;21(1):59-70 [124659.001]
  • [Cites] Biosci Rep. 1985 Sep;5(9):765-74 [2935202.001]
  • [Cites] Exp Eye Res. 2000 Mar;70(3):349-62 [10712821.001]
  • [Cites] J Biochem. 1995 Apr;117(4):707-18 [7592530.001]
  • [Cites] J Biol Chem. 1996 Apr 19;271(16):9759-63 [8621655.001]
  • [Cites] J Biol Chem. 2005 Jul 8;280(27):25541-7 [15849191.001]
  • [Cites] Mol Vis. 2002 Oct 31;8:407-15 [12432342.001]
  • [Cites] Matrix Biol. 2003 Nov;22(6):467-75 [14667839.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3365-73 [11006226.001]
  • [Cites] J Biol Chem. 1992 Jan 5;267(1):347-52 [1370446.001]
  • [Cites] J Biol Chem. 1997 Oct 31;272(44):28089-95 [9346963.001]
  • [Cites] J Biol Chem. 1976 Nov 10;251(21):6513-21 [988023.001]
  • [Cites] J Biol Chem. 1991 Dec 25;266(36):24773-7 [1761572.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1750-6 [11431438.001]
  • [Cites] Exp Eye Res. 1999 Sep;69(3):267-77 [10471335.001]
  • [Cites] Ophthalmic Res. 2003 Jul-Aug;35(4):177-84 [12815192.001]
  • (PMID = 17851677.001).
  • [ISSN] 0948-6143
  • [Journal-full-title] Histochemistry and cell biology
  • [ISO-abbreviation] Histochem. Cell Biol.
  • [Language] eng
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / / B18021; United Kingdom / Biotechnology and Biological Sciences Research Council / / BBS/B/10994; United Kingdom / Arthritis Research UK / / 13279; United Kingdom / Biotechnology and Biological Sciences Research Council / / bbs/b/10994
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Proteoglycans; 9056-36-4 / Keratan Sulfate
  •  go-up   go-down


83. Lo W, Chang YL, Liu JS, Hseuh CM, Hovhannisyan V, Chen SJ, Tan HY, Dong CY: Multimodal, multiphoton microscopy and image correlation analysis for characterizing corneal thermal damage. J Biomed Opt; 2009 Sep-Oct;14(5):054003
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multimodal, multiphoton microscopy and image correlation analysis for characterizing corneal thermal damage.
  • We used the combination of multiphoton autofluorescence (MAF), forward second-harmonic generation (FWSHG), and backward second-harmonic generation (BWSHG) imaging for the qualitative and quantitative characterization of thermal damage of ex vivo bovine cornea.
  • Our results show that while MAF and BWSHG intensities may be used as preliminary indicators of the extent of corneal thermal damage, the most sensitive measures are provided by the decay in FWSHG intensity and the convergence of FWSHG and BWSHG images.
  • [MeSH-major] Cornea / pathology. Corneal Injuries. Eye Burns / pathology. Image Enhancement / methods. Microscopy, Fluorescence, Multiphoton / methods. Subtraction Technique

  • MedlinePlus Health Information. consumer health - Corneal Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19895105.001).
  • [ISSN] 1560-2281
  • [Journal-full-title] Journal of biomedical optics
  • [ISO-abbreviation] J Biomed Opt
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


84. Ku JY, Niederer RL, Patel DV, Sherwin T, McGhee CN: Laser scanning in vivo confocal analysis of keratocyte density in keratoconus. Ophthalmology; 2008 May;115(5):845-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Keratoconus is a form of progressive noninflammatory corneal ectasia.
  • Although abnormalities have been documented at every level of the keratoconic cornea, the exact underlying pathophysiologic process remains unknown.
  • In subjects with keratoconus, anterior keratocyte density correlated with central corneal thickness (r = 0.426, P = 0.012) and inversely with steepest keratometry values (r = -0.383, P = 0.028).
  • In vivo confocal microscopy offers the opportunity to study early microstructural changes in the keratoconic cornea.
  • [MeSH-major] Corneal Stroma / pathology. Keratoconus / pathology. Microscopy, Confocal

  • Genetic Alliance. consumer health - Keratoconus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17825419.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


85. Wollensak G, Aurich H, Pham DT, Wirbelauer C: Hydration behavior of porcine cornea crosslinked with riboflavin and ultraviolet A. J Cataract Refract Surg; 2007 Mar;33(3):516-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hydration behavior of porcine cornea crosslinked with riboflavin and ultraviolet A.
  • PURPOSE: To examine the influence of a new crosslinking treatment on corneal swelling properties that correlate with the degree of crosslinking.
  • RESULTS: Using light microscopy, a characteristic swelling pattern with 3 zones was identified in the crosslinked porcine cornea: an anterior intensely crosslinked zone of 242 microm, an intermediate partially crosslinked zone of 238 microm (hydration factor 2.2), and a noncrosslinked posterior zone of 1355 microm (hydration factor 2.7).
  • In the nonhydrated state of the crosslinked cornea, the anterior zone was deduced to be 242 microm; the intermediate zone, 109 microm; and the posterior zone, 501 microm.
  • Crosslinked cornea did not induce a specific signal on OCT, and OCT is therefore not suited for clinical controls of the crosslinking effect.
  • [MeSH-major] Collagen / metabolism. Corneal Edema / metabolism. Corneal Stroma / drug effects. Cross-Linking Reagents / radiation effects. Photosensitizing Agents / pharmacology. Riboflavin / pharmacology. Ultraviolet Rays. Water / metabolism

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. Water .
  • Hazardous Substances Data Bank. Riboflavin .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Cataract Refract Surg. 2008 Jun;34(6):879-80 [18498973.001]
  • [CommentIn] J Cataract Refract Surg. 2007 Sep;33(9):1503 [17720054.001]
  • (PMID = 17321404.001).
  • [ISSN] 0886-3350
  • [Journal-full-title] Journal of cataract and refractive surgery
  • [ISO-abbreviation] J Cataract Refract Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cross-Linking Reagents; 0 / Photosensitizing Agents; 059QF0KO0R / Water; 9007-34-5 / Collagen; TLM2976OFR / Riboflavin
  •  go-up   go-down


86. Banitt MR, Malta JB, Mian SI, Soong HK: Rupture of anterior lens capsule from blunt ocular injury. J Cataract Refract Surg; 2009 May;35(5):943-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We propose that the anterior lens capsule may have been torn by direct contusion from rapid focal indentation of the cornea onto the lens (coup injury) or by a fluid-mechanical, anteriorly directed rebound of the vitreous, bursting open the anterior capsule (contrecoup injury).

  • MedlinePlus Health Information. consumer health - Cataract.
  • MedlinePlus Health Information. consumer health - Eye Injuries.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19393898.001).
  • [ISSN] 1873-4502
  • [Journal-full-title] Journal of cataract and refractive surgery
  • [ISO-abbreviation] J Cataract Refract Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


87. de Melo GB, Aggio FB, Höfling-Lima AL, d'Azevedo PA, Pignatari AC: Pulsed-field gel electrophoresis in the identification of the origin of bacterial keratitis caused by Pseudomonas aeruginosa. Graefes Arch Clin Exp Ophthalmol; 2007 Jul;245(7):1053-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cultures were positive for Pseudomonas aeruginosa in the cornea and conjunctiva, and in the contact lens, its case and the cleaning solution.
  • [MeSH-major] Corneal Ulcer / diagnosis. Electrophoresis, Gel, Pulsed-Field. Eye Infections, Bacterial / diagnosis. Pseudomonas Infections / diagnosis
  • [MeSH-minor] Adult. Anti-Bacterial Agents / therapeutic use. Cephalothin / therapeutic use. Conjunctiva / microbiology. Contact Lenses / microbiology. Cornea / microbiology. DNA, Bacterial / analysis. Drug Therapy, Combination. Female. Gentamicins / therapeutic use. Humans. Pseudomonas aeruginosa / genetics. Pseudomonas aeruginosa / isolation & purification

  • Hazardous Substances Data Bank. CEPHALOTHIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Adv Appl Microbiol. 2003;53:243-70 [14696321.001]
  • [Cites] Braz J Infect Dis. 2003 Feb;7(1):32-43 [12807690.001]
  • [Cites] Cornea. 2005 Jan;24(1):51-8 [15604867.001]
  • [Cites] Diagn Microbiol Infect Dis. 1993 Jul;17(1):13-8 [8359000.001]
  • [Cites] Lancet. 1999 Jul 17;354(9174):181-5 [10421298.001]
  • (PMID = 17186257.001).
  • [ISSN] 0721-832X
  • [Journal-full-title] Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
  • [ISO-abbreviation] Graefes Arch. Clin. Exp. Ophthalmol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / DNA, Bacterial; 0 / Gentamicins; R72LW146E6 / Cephalothin
  •  go-up   go-down


88. Zhou X, Rho SH, Yoo KW, Ahn HB, Kim TH, Yoo YH, Kim JC, Park WC: Amniotic membrane corrects surgically induced astigmatism. Ophthalmologica; 2006;220(6):389-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We performed photoastigmatic refractive keratectomy (PARK) on rabbits and grafted AM on the cornea.
  • [MeSH-minor] Animals. Corneal Topography. Lasers, Excimer. Rabbits

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 S. Karger AG, Basel.
  • (PMID = 17095885.001).
  • [ISSN] 0030-3755
  • [Journal-full-title] Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde
  • [ISO-abbreviation] Ophthalmologica
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  •  go-up   go-down


89. Hasenson S, Määttä M, Rousselle P, Kikkawa Y, Miner JH, Tervo T, Virtanen I: The immortalized human corneal epithelial cells adhere to laminin-10 by using Lutheran glycoproteins and integrin alpha3beta1. Exp Eye Res; 2005 Oct;81(4):415-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The immortalized human corneal epithelial cells adhere to laminin-10 by using Lutheran glycoproteins and integrin alpha3beta1.
  • We studied the adhesion characteristics of immortalized human corneal epithelial (HCE) cells on purified human laminin (Ln)-10 (alpha5beta1gamma1).
  • Immunofluorescence studies with monoclonal antibodies (MAb) revealed the presence of laminin alpha5 chain receptor Lutheran (Lu) in vivo on the basal cells of cornea and as punctate cell surface-confined reactivity on adhering and spread HCE cells, while alpha- and beta-dystroglycans could not be found.
  • [MeSH-major] Epithelium, Corneal / metabolism. Integrin alpha3beta1 / physiology. Laminin / metabolism. Lutheran Blood-Group System / physiology

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16185953.001).
  • [ISSN] 0014-4835
  • [Journal-full-title] Experimental eye research
  • [ISO-abbreviation] Exp. Eye Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Integrin alpha3beta1; 0 / Laminin; 0 / Lutheran Blood-Group System; 0 / RNA, Messenger; 0 / laminin 10; 146888-27-9 / Dystroglycans
  •  go-up   go-down


90. Holopainen J, Krootila K: [Keratoconus]. Duodecim; 2010;126(2):152-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinical manifestations of keratoconus include reduced visual acuity, increased astigmatism, thinning of the cornea and protrusion of the cornea, as observed in the shape of the corneal surface.
  • A corneal transplant operation is applied to a far-advanced keratoconus.
  • Photohardening of the cornea may serve as a suitable preventive treatment.
  • [MeSH-major] Contact Lenses. Corneal Transplantation. Eyeglasses. Keratoconus / pathology. Keratoconus / therapy
  • [MeSH-minor] Corneal Topography. Disease Progression. Humans. Visual Acuity / physiology

  • Genetic Alliance. consumer health - Keratoconus.
  • MedlinePlus Health Information. consumer health - Eye Wear.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20405600.001).
  • [ISSN] 0012-7183
  • [Journal-full-title] Duodecim; lääketieteellinen aikakauskirja
  • [ISO-abbreviation] Duodecim
  • [Language] fin
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Finland
  • [Number-of-references] 22
  •  go-up   go-down


91. Cheong WK: Gentle cleansing and moisturizing for patients with atopic dermatitis and sensitive skin. Am J Clin Dermatol; 2009;10 Suppl 1:13-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Inflammation disrupts the barrier function of the stratum corneum, predisposing the skin to be dry, and increases susceptibility to irritants and secondary bacterial infection.
  • Moisturizers improve skin hydration, reduce susceptibility to irritation, restore the integrity of the stratum corneum, and enhance the efficacy of topical corticosteroids.

  • Genetic Alliance. consumer health - Eczema.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19209949.001).
  • [ISSN] 1179-1888
  • [Journal-full-title] American journal of clinical dermatology
  • [ISO-abbreviation] Am J Clin Dermatol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] New Zealand
  • [Chemical-registry-number] 0 / Detergents; 0 / Emollients
  •  go-up   go-down


92. Yagi E, Ohmori T, Sakamoto K: Polyoxyethylene/polyoxypropylen dimethyl ether (EPDME) improves the structure of intercellular lipids in SDS-induced dry skin. J Cosmet Sci; 2010 Jan-Feb;61(1):39-48
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We examined whether EPDME is effective for skin moisturization by means of electron paramagnetic resonance (EPR) studies of ex vivo specimens of stratum corneum (SC) obtained by successive stripping.

  • Hazardous Substances Data Bank. POLOXALENE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20211116.001).
  • [ISSN] 1525-7886
  • [Journal-full-title] Journal of cosmetic science
  • [ISO-abbreviation] J Cosmet Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Emulsions; 9003-11-6 / Poloxalene
  •  go-up   go-down


93. Lim LS, Aung HT, Aung T, Tan DT: Corneal imaging with anterior segment optical coherence tomography for lamellar keratoplasty procedures. Am J Ophthalmol; 2008 Jan;145(1):81-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Corneal imaging with anterior segment optical coherence tomography for lamellar keratoplasty procedures.
  • PURPOSE: To assess and describe the uses of anterior segment optical coherence tomography (OCT) in the evaluation of the cornea before and after lamellar corneal transplantation procedures.
  • METHODS: Seven eyes of seven patients undergoing anterior and posterior lamellar corneal transplantation procedures at the Singapore National Eye Centre were included in the study.
  • High-resolution anterior segment OCT scans of the cornea and anterior segment were performed both before and after lamellar transplantation procedures on the cornea with the Visante anterior segment OCT system (Visante OCT; Carl Zeiss Meditec, Inc, Dublin, California, USA), and the imaging findings were correlated with the clinical picture.
  • CONCLUSIONS: Anterior segment OCT is a valuable imaging tool for assessing the feasibility of lamellar transplantation surgery in the diseased cornea and in the management of surgical complications after such procedures.
  • [MeSH-major] Anterior Chamber / pathology. Cornea / pathology. Corneal Diseases / surgery. Corneal Transplantation / pathology. Diagnostic Techniques, Ophthalmological. Tomography, Optical Coherence / methods

  • MedlinePlus Health Information. consumer health - Corneal Disorders.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18028862.001).
  • [ISSN] 0002-9394
  • [Journal-full-title] American journal of ophthalmology
  • [ISO-abbreviation] Am. J. Ophthalmol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Barboza AP, Pereira RC, Garcia CD, Garcia VD: Project of cornea donation in the hospital complex of Santa Casa de Porto Alegre, Brazil. Transplant Proc; 2007 Mar;39(2):341-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Project of cornea donation in the hospital complex of Santa Casa de Porto Alegre, Brazil.
  • Up to 2000, there were 11 to 15 cornea donors and 70 to 80 transplantations yearly.
  • Whenever donation was authorized, the coordinator communicated with the Cornea Bank to perform a removal.
  • There was a major increase in the number of donations (220/y) with this project responsible for more than 70% of the cornea donors on cardiac arrest in the Rio Grande do Sul State.
  • This model was efficient, and must be implemented in other hospitals in the state, attempting to decrease both the list and the waiting time for a corneal transplant.
  • [MeSH-major] Cornea. Corneal Transplantation / statistics & numerical data. Tissue and Organ Procurement / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17362724.001).
  • [ISSN] 0041-1345
  • [Journal-full-title] Transplantation proceedings
  • [ISO-abbreviation] Transplant. Proc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


95. Rerek ME, Van Wyck D, Mendelsohn R, Moore DJ: FTIR spectroscopic studies of lipid dynamics in phytosphingosine ceramide models of the stratum corneum lipid matrix. Chem Phys Lipids; 2005 Mar;134(1):51-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] FTIR spectroscopic studies of lipid dynamics in phytosphingosine ceramide models of the stratum corneum lipid matrix.
  • The implications of these observations for lipid organization in the stratum corneum are briefly discussed.

  • Hazardous Substances Data Bank. Water .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15752463.001).
  • [ISSN] 0009-3084
  • [Journal-full-title] Chemistry and physics of lipids
  • [ISO-abbreviation] Chem. Phys. Lipids
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Ceramides; 0 / Lipids; 059QF0KO0R / Water; GIN46U9Q2Q / phytosphingosine; NGZ37HRE42 / Sphingosine
  •  go-up   go-down


96. Haque S, Jones L, Simpson T: Thickness mapping of the cornea and epithelium using optical coherence tomography. Optom Vis Sci; 2008 Oct;85(10):E963-76
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Thickness mapping of the cornea and epithelium using optical coherence tomography.
  • PURPOSE: To measure corneal and epithelial thickness across four meridians using Optical Coherence Tomography (OCT) and to compare these measurements between normal non-lens wearers (NLW), rigid gas permeable (RGP) lens wearers, and RGP-wearing keratoconics (KC).
  • A customized fixation target employing LEDs in eight directions of gaze was attached to the OCT and corneal images obtained.
  • Raw OCT scans were analyzed to yield values for corneal and epithelial thickness and color-coded maps were compiled.
  • RESULTS: Central corneal thickness (CCT) was thinnest in KC (447 +/- 68 microm) and similar between RGP (518 +/- 32 microm; pKC < 0.001) and NLW (517 +/- 21 microm) (p(KC) < 0.001 NLW pRGP > 0.05).
  • Peripheral corneal thickness in NLW was thickest in the superior temporal and thinnest in the inferior (I) regions (superior temporal(thickest) vs. I(thinnest) p < 0.001).
  • CONCLUSIONS: Thickness of the normal cornea and epithelium was greatest in the superior region.
  • In all groups, the inferior cornea and epithelium was thinnest, and to a greater extent in the KC group.
  • [MeSH-major] Contact Lenses. Cornea / pathology. Corneal Topography / methods. Epithelium, Corneal / pathology. Keratoconus / pathology. Tomography, Optical Coherence
  • [MeSH-minor] Adult. Corneal Stroma / pathology. Equipment Design. Female. Humans. Male. Young Adult

  • MedlinePlus Health Information. consumer health - Eye Wear.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18832971.001).
  • [ISSN] 1538-9235
  • [Journal-full-title] Optometry and vision science : official publication of the American Academy of Optometry
  • [ISO-abbreviation] Optom Vis Sci
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


97. Sonoda KH, Nakao S, Nakamura T, Oshima T, Qiao H, Hisatomi T, Kinoshita S, Ishibashi T: Cellular events in the normal and inflamed cornea. Cornea; 2005 Nov;24(8 Suppl):S50-S54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cellular events in the normal and inflamed cornea.
  • PURPOSE: Although normal cornea is an avascular transparent structure, bone marrow (BM)-derived cells exist in situ even in noninflamed conditions.
  • We evaluated constitutive cellular trafficking into the cornea in the naive state and investigated how corneal inflammation may be initiated by various stimuli.
  • To analyze initiation of cellular events in corneal immune response, we cauterized the center of the cornea or inoculated IL-1 beta into the corneal micropocket.
  • RESULTS: At 2 weeks after BM transplantation, GFP cells gradually migrated into the cornea from the limbal area and were distributed over the entire cornea at 6 months.
  • Depletion of neutrophils by anti-Gr-1 Ab significantly reduced corneal edema/opacity induced by cauterization.
  • CONCLUSIONS: BM-derived cells are recruited into the normal cornea and may be essential to maintain corneal clarity.
  • In the inflamed cornea, neutrophils might be responsible for acute corneal edema/opacity and macrophages for corneal angiogenesis and chronic inflammation.
  • [MeSH-minor] Animals. Bone Marrow Cells / cytology. Bone Marrow Transplantation. Cautery. Cell Lineage. Cell Movement. Chemokine CCL2 / deficiency. Chimera. Corneal Neovascularization / chemically induced. Drug Implants. Female. Immunity, Cellular. Interleukin-1 / administration & dosage. Macrophages / pathology. Mice. Mice, Inbred Strains. Mice, Transgenic. Neutrophils

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16227824.001).
  • [ISSN] 0277-3740
  • [Journal-full-title] Cornea
  • [ISO-abbreviation] Cornea
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ccl2 protein, mouse; 0 / Chemokine CCL2; 0 / Drug Implants; 0 / Interleukin-1
  •  go-up   go-down


98. Zhivov A, Stave J, Vollmar B, Guthoff R: In vivo confocal microscopic evaluation of langerhans cell density and distribution in the corneal epithelium of healthy volunteers and contact lens wearers. Cornea; 2007 Jan;26(1):47-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] In vivo confocal microscopic evaluation of langerhans cell density and distribution in the corneal epithelium of healthy volunteers and contact lens wearers.
  • PURPOSE: To examine and compare the density and distribution of Langerhans cells (LCs) in the corneal epithelium of healthy volunteers and contact lens wearers.
  • METHODS: A total of 225 eyes of 130 healthy volunteers (age, 17-81 years) without history of ocular inflammation, trauma, or surgery and 98 eyes of 55 contact lens wearers (age, 13-76 years) were examined in vivo with the combination of the Heidelberg Retina Tomograph II and in-house-invented Rostock Cornea Module.
  • RESULTS: In healthy volunteers, in vivo confocal microscopy revealed LCs in 31% of all volunteers, with 37 of these 43 volunteers presenting LCs both in the center and the periphery of the cornea with densities of 34 +/- 3 and 98 +/- 8 cells/mm, respectively.
  • Although LC densities were markedly higher in both the central (78 +/- 25 cells/mm) and the peripheral cornea (210 +/- 24 cells/mm) of contact lens wearers, the gradient of LC density from peripheral to central cornea was found almost identical in both groups.
  • In the central cornea, LC density decreased with duration of contact lens wear.
  • CONCLUSIONS: In vivo confocal microscopy enables evaluation of LC density and distribution in corneal epithelium.
  • LCs were found present both in the center and the periphery of the cornea without difference in distribution between healthy volunteers and contact lens wearers.
  • However, contact lens wearers revealed almost twofold higher LC densities in both locations, implying chronic mechanical irritation of the cornea in response to the contact lens as foreign body.
  • [MeSH-major] Contact Lenses / utilization. Epithelium, Corneal / cytology. Langerhans Cells / cytology. Microscopy, Confocal

  • MedlinePlus Health Information. consumer health - Eye Wear.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17198013.001).
  • [ISSN] 0277-3740
  • [Journal-full-title] Cornea
  • [ISO-abbreviation] Cornea
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


99. Leiper LJ, Walczysko P, Kucerova R, Ou J, Shanley LJ, Lawson D, Forrester JV, McCaig CD, Zhao M, Collinson JM: The roles of calcium signaling and ERK1/2 phosphorylation in a Pax6+/- mouse model of epithelial wound-healing delay. BMC Biol; 2006 Aug 16;4:27
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is not clear whether the keratopathy is a direct result of reduced PAX6 gene dosage in the cornea itself, or due to recurrent corneal trauma secondary to defects such as dry eye caused by loss of PAX6 in other tissues.
  • We investigated the hypothesis that reducing Pax6 gene dosage leads to corneal wound-healing defects. and assayed the immediate molecular responses to wounding in wild-type and mutant corneal epithelial cells.
  • RESULTS: Pax6+/- mouse corneal epithelia exhibited a 2-hour delay in their response to wounding, but subsequently the cells migrated normally to repair the wound.
  • A model is presented whereby minor abrasions, which are quickly healed in normal corneas, transiently persist in aniridic patients, compromising the corneal stroma.

  • COS Scholar Universe. author profiles.
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Invest Ophthalmol Vis Sci. 2003 May;44(5):1871-8 [12714618.001]
  • [Cites] J Cell Sci. 2003 Jun 1;116(Pt 11):2157-67 [12692153.001]
  • [Cites] Cell Tissue Res. 2003 May;312(2):203-20 [12715147.001]
  • [Cites] Exp Cell Res. 2003 Jul 15;287(2):209-18 [12837277.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Jul;4(7):517-29 [12838335.001]
  • [Cites] Am J Ophthalmol. 2003 Sep;136(3):530-6 [12967809.001]
  • [Cites] J Membr Biol. 2003 Jul 1;194(1):47-58 [14502442.001]
  • [Cites] Mol Cell Biol. 2004 Jan;24(1):245-57 [14673159.001]
  • [Cites] J Cell Biochem. 2004 Apr 1;91(5):938-50 [15034929.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1101-8 [15037575.001]
  • [Cites] Curr Biol. 2004 Apr 20;14(8):731-5 [15084290.001]
  • [Cites] Development. 2004 Jul;131(13):3021-34 [15197160.001]
  • [Cites] J Cell Sci. 2004 Sep 15;117(Pt 20):4681-90 [15371524.001]
  • [Cites] J Biol Chem. 2004 Oct 22;279(43):44513-21 [15316018.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1983 Oct;24(10):1442-3 [6618809.001]
  • [Cites] J Pediatr Ophthalmol Strabismus. 1983 Sep-Oct;20(5):192-8 [6631651.001]
  • [Cites] Surv Ophthalmol. 1984 May-Jun;28(6):621-42 [6330922.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1985 Jan;26(1):105-10 [3871430.001]
  • [Cites] Exp Eye Res. 1985 Sep;41(3):335-43 [3877641.001]
  • [Cites] Cell. 1989 Apr 21;57(2):201-9 [2702690.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1990 Sep;31(9):1773-8 [2211024.001]
  • [Cites] Nature. 1991 Dec 19-26;354(6354):522-5 [1684639.001]
  • [Cites] Exp Cell Res. 1997 Feb 1;230(2):197-207 [9024779.001]
  • [Cites] Science. 1997 Apr 4;276(5309):75-81 [9082989.001]
  • [Cites] J Neurosci Res. 1999 Oct 1;58(1):88-95 [10491574.001]
  • [Cites] Biol Res. 2006;39(1):189-90 [16629179.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2006 May;47(5):1911-7 [16638998.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Jun 2;344(2):680-7 [16630542.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2397-407 [16723449.001]
  • [Cites] J Cell Biochem. 2004 Dec 15;93(6):1115-33 [15449317.001]
  • [Cites] Int J Biochem Cell Biol. 2005 Mar;37(3):547-57 [15618012.001]
  • [Cites] J Biol Chem. 2005 Apr 1;280(13):12988-95 [15659382.001]
  • [Cites] Am J Physiol Cell Physiol. 2005 Jun;288(6):C1420-30 [15897322.001]
  • [Cites] Exp Eye Res. 2005 Aug;81(2):224-35 [16080917.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4097-106 [16249486.001]
  • [Cites] Nat Rev Neurosci. 2006 Feb;7(2):115-25 [16429121.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G782-92 [16282360.001]
  • [Cites] Am J Physiol Cell Physiol. 2000 Feb;278(2):C303-14 [10666025.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2000 May;41(6):1346-55 [10798649.001]
  • [Cites] Dev Biol. 2000 Jun 1;222(1):41-54 [10885745.001]
  • [Cites] Bioessays. 2000 Oct;22(10):911-9 [10984717.001]
  • [Cites] Development. 2000 Dec;127(23):5167-78 [11060242.001]
  • [Cites] J Cell Biochem. 2001;80(3):397-414 [11135371.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2001 Feb;280(2):L221-8 [11159000.001]
  • [Cites] Nat Cell Biol. 2001 May;3(5):E117-23 [11331897.001]
  • [Cites] Exp Biol Med (Maywood). 2001 Jul;226(7):653-64 [11444101.001]
  • [Cites] Prog Retin Eye Res. 2001 Sep;20(5):625-37 [11470453.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9688-93 [11481423.001]
  • [Cites] J Membr Biol. 2001 Sep 15;183(2):93-101 [11562791.001]
  • [Cites] J Cell Sci. 2001 Dec;114(Pt 23):4185-95 [11739651.001]
  • [Cites] J Biol Chem. 2002 Mar 29;277(13):11539-48 [11790784.001]
  • [Cites] Mech Dev. 2002 Oct;118(1-2):3-17 [12351165.001]
  • [Cites] Dev Biol. 2003 Mar 15;255(2):303-12 [12648492.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1402-5 [12657570.001]
  • [Cites] Cell. 1991 Dec 20;67(6):1059-74 [1684738.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1992 Apr;33(5):1756-65 [1559775.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1992 May;33(6):1987-95 [1582803.001]
  • [Cites] Exp Eye Res. 1993 Sep;57(3):293-300 [8224017.001]
  • [Cites] J Cell Sci. 1993 Dec;106 ( Pt 4):995-1004 [8126116.001]
  • [Cites] Nat Genet. 1994 Feb;6(2):168-73 [8162071.001]
  • [Cites] Nat Genet. 1992 Nov;2(3):232-9 [1345175.001]
  • [Cites] Pflugers Arch. 1994 Jul;427(5-6):533-42 [7971152.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1995 Mar;36(3):614-21 [7534282.001]
  • [Cites] Development. 1995 May;121(5):1433-42 [7789273.001]
  • [Cites] Am J Ophthalmol. 1995 Sep;120(3):368-75 [7661209.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1987 Feb;28(2):205-11 [8591897.001]
  • [Cites] Cell. 1996 Jul 12;86(1):71-82 [8689689.001]
  • [Cites] Ophthalmic Res. 1996;28(1):50-6 [8726677.001]
  • [Cites] J Neurosci. 1996 Sep 1;16(17):5425-36 [8757255.001]
  • [Cites] J Cell Sci. 1996 Feb;109 ( Pt 2):355-65 [8838659.001]
  • [Cites] Curr Opin Ophthalmol. 1996 Aug;7(4):2-11 [10163634.001]
  • (PMID = 16914058.001).
  • [ISSN] 1741-7007
  • [Journal-full-title] BMC biology
  • [ISO-abbreviation] BMC Biol.
  • [Language] ENG
  • [Grant] United Kingdom / Wellcome Trust / / 068012; United Kingdom / Wellcome Trust / / 068932; United Kingdom / Wellcome Trust / / 074127
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Eye Proteins; 0 / Homeodomain Proteins; 0 / PAX6 protein; 0 / Paired Box Transcription Factors; 0 / Repressor Proteins; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 1
  • [Other-IDs] NLM/ PMC1563477
  •  go-up   go-down


100. Das S, Ramamurthy B, Sangwan VS: Deep lamellar keratoplasty for recurrent advanced pterygium. Ophthalmic Surg Lasers Imaging; 2009 Jan-Feb;40(1):43-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A woman presented with bilateral recurrent advanced pterygium (more prevalent in the left eye) associated with corneal thinning in the left eye.
  • Two-thirds of the cornea was covered by pterygia.
  • Clarity, state of corneal graft, and postoperative visual acuity were noted.
  • [MeSH-major] Corneal Transplantation. Pterygium / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19205495.001).
  • [ISSN] 1542-8877
  • [Journal-full-title] Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye
  • [ISO-abbreviation] Ophthalmic Surg Lasers Imaging
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement